SENATE AMENDED
PRIOR PRINTER'S NOS. 940, 1546, 2432, PRINTER'S NO. 2553
2510
No. 851 Session of 1971
INTRODUCED BY MR. BERKES, MRS. CRAWFORD, MRS. ANDERSON, MESSRS.
GREENFIELD, SCANLON, MILLER, SAVITT, J. H. HAMILTON,
GALLAGHER, BRAIG, KNEPPER, R. W. WILT, MELTON, FEE, MRS.
KELLY, MESSRS. BELLOMINI, DeMEDIO, HASKELL, DOMBROWSKI,
BLAIR, RITTER, D. S. HAYES, O'PAKE, PIEVSKY, FINEMAN,
ENGLEHART, IRVIS, MRS. FAWCETT, MESSRS. TAYLOR, O'BRIEN,
KURY, WANSACZ, MALADY, COMER, DAGER, H. S. PARKER, STONE,
B. L. PARKER, PEZAK, SHERMAN, BARBER, J. J. JOHNSON, DOYLE,
KELLY, E. B. DAVIS, FRANK, LUTTY, HUTCHINSON, ARTHURS,
CROWLEY, RAPPAPORT, RIEGER, KOWALYSHYN, MRS. TOLL, MESSRS.
BERSON, WOJDAK, SCHMITT, ZELLER, MEHOLCHICK, MANDERINO,
HOVIS, EARLY, McMONAGLE, BENNETT, KLEPPER, DREIBELBIS,
PERRY, MORRIS, YAHNER, KLUNK, GLEASON, STEMMLER, NEEDHAM,
D. M. DAVIS, MEBUS, F. M. ALLEN, ZORD, HALVERSON, WRIGHT,
PIPER, WISE, HETRICK, PRENDERGAST, GELFAND, LAUDADIO,
BONETTO, SHELHAMER, KOLTER, R. O. DAVIS, HOPKINS, WEIDNER,
LETTERMAN, SCIRICA, MARTINO, LEDERER, COPPOLINO, SULLIVAN,
GEISLER, CAPUTO, WILLIAMS, SHUPNIK, COYNE, M. M. MULLEN,
MRS. GILLETTE, MESSRS. VANN, RUSH, FRANCIS LYNCH,
ECKENSBERGER, SCHEAFFER, USTYNOSKI, YOHN, LEHR, GALLEN,
BURKARDT, O'CONNELL, WELLS, O'DONNELL, WARGO, CESSAR,
NOVAK, McCLATCHY AND FRYER, MAY 3, 1971
AS AMENDED ON SECOND CONSIDERATION, IN SENATE, FEBRUARY 28, 1972
AN ACT
1 Relating to the manufacture, sale and possession of CONTROLLED <--
2 SUBSTANCES, OTHER drugs, devices and cosmetics; conferring
3 powers on the courts and the secretary and Department of
4 Health and a newly created Pennsylvania Drug, Device and
5 Cosmetic Board; establishing schedules of controlled drugs <--
6 and dangerous substances; providing penalties; requiring
7 registration of persons engaged in the drug trade and for the
8 revocation or suspension of certain licenses and
9 registrations; and repealing an act.
10 The General Assembly of the Commonwealth of Pennsylvania
1 hereby enacts as follows:
2 Section 1. Short Title.--This act shall be known and may be
3 cited as "The CONTROLLED SUBSTANCE, Drug, Device and Cosmetic <--
4 Act." of 1971." <--
5 Section 2. Definitions.--As used in this act: <--
6 SECTION 2. DEFINITIONS.--(A) THE DEFINITIONS CONTAINED AND <--
7 USED IN THE "PENNSYLVANIA DRUG AND ALCOHOL ABUSE CONTROL ACT"
8 SHALL ALSO APPLY FOR PURPOSES OF THIS ACT.
9 (B) AS USED IN THIS ACT:
10 (1) "Drug" means (i) substances recognized in the official <--
11 United States Pharmacopoeia, official Homeopathic Pharmacopoeia
12 of the United States, or official National Formulary, or any
13 supplement to any of them; and (ii) substances intended for use
14 in the diagnosis, cure, mitigation, treatment or prevention of
15 disease in man or other animals; and (iii) substances (other
16 than food) intended to affect the structure or any function of
17 the body of man or other animals; and (iv) substances intended
18 for use as a component of any substance specified in clause (i),
19 (ii) or (iii), but not including devices or their components,
20 parts or accessories: Provided, That the drug provisions of this
21 act shall not apply to medicated feed intended for and used
22 exclusively as food for animals other than man: And provided
23 further, That the drug provisions as provided in this act shall
24 not apply to such vitamins, minerals and chemicals when used in
25 the processing and manufacture of foods and non-alcoholic
26 beverages specifically permitted under existing State and
27 Federal statutes as food and color additives. The term shall
28 include substances controlled by the secretary under the
29 provisions of sections 3 and 4 of this act.
30 (2) "Device" means instruments, apparatus and contrivances,
19710H0851B2553 - 2 -
1 including their components, parts and accessories, intended (i)
2 for use in the diagnosis, cure, mitigation, treatment or
3 prevention of disease of man or other animals; or (ii) to affect
4 the structure or any function of the body of man or other
5 animals.
6 (3) "Cosmetic" means (i) substances intended to be rubbed,
7 poured, sprinkled or sprayed on, introduced into or otherwise
8 applied to the human body or any part thereof for cleansing,
9 beautifying, promoting attractiveness or altering the
10 appearance, and (ii) substances intended for use as a component
11 of any such substances, except that such term shall not include
12 soap.
13 (4) "Addict" means any individual who habitually uses any
14 narcotic drug so as to endanger the public morals, health,
15 safety or welfare, or who is so far addicted to the use of
16 narcotic drugs as to have lost the power of self-control with
17 reference to his addiction.
18 (5) "Administer" means to transfer or deliver a controlled
19 drug or controlled dangerous substance by a practitioner or his
20 authorized agent, in his presence, to an ultimate user or human
21 research subject by injection, or for inhalation or ingestion,
22 or by any other means involving the actual use of the drug.
23 (6) "Advertisement" means any representation, disseminated
24 in any manner or by any means other than by labeling, for the
25 purpose of inducing or which is likely to induce, directly or
26 indirectly, the purchase and/or use of a drug, device or
27 cosmetic.
28 (7) "Board" means the Pennsylvania Drug, Device and Cosmetic
29 Board.
30 (8) "Color additive" means a material which is a dye,
19710H0851B2553 - 3 -
1 pigment or other substance made by a process of synthesis or
2 similar artifice, or extracted, isolated or otherwise derived,
3 with or without intermediate or final change of identity, from a
4 vegetable, animal, mineral or other source, and, when added or
5 applied to a drug or cosmetic or to the human body, is capable,
6 alone or through reaction with another substance, of imparting
7 color thereto, except that such term does not include any
8 material which the appropriate authority, pursuant to the
9 Federal act, determines is used or intended to be used solely
10 for a purpose or purposes other than coloring. The term "color"
11 includes black, white and intermediate grays.
12 (9) "Council" means the Governor's Council on Drug,
13 Narcotics and Alcohol Abuse.
14 (10) "Contaminated with filth" means consisting, in whole or
15 in part, of any decomposed, putrid or filthy substance, or
16 prepared, packed or held under any unsanitary condition or
17 exposed whereby the article or product concerned may have become
18 contaminated with filth, dirt, dust or any foreign material, or
19 in any manner rendered injurious to health.
20 (11) "Contraband" means any controlled drug or controlled
21 dangerous substance possessed by a person not authorized by law
22 to possess such drug or substance, or obtained or held in a
23 manner contrary to the provisions of this act.
24 (12) "Control" means to add, remove, or change the placement
25 of a drug, substance, or immediate precursor under the
26 provisions of sections 3 and 4 of this act.
27 (13) "Controlled dangerous substance" means a drug,
28 substance or immediate precursor in the schedules set forth in
29 section 4.
30 (14) "Controlled drug" includes:
19710H0851B2553 - 4 -
1 (i) Any "narcotic drug" means any of the following, whether
2 produced directly or indirectly by extraction from substances of
3 vegetable origin, or independently by means of chemical
4 synthesis or by a combination of extraction and chemical
5 synthesis: (A) opium and coca leaves, (B) any opiate having an
6 addiction-forming or addiction-sustaining capacity similar to
7 morphine, (C) any compound, manufacture, salt, derivative, or
8 preparation of opium or coca leaves or any opiate, and (D) any
9 substance, and any compound, manufacture, salt, derivative, or
10 preparation thereof, which is chemically identical with any of
11 the substances referred to in (A), (B), or (C); except that it
12 shall not include decocainized coca leaves, or extracts of coca
13 leaves which do not contain cocaine or ecgonine;
14 (ii) "Depressant or stimulant drug" means: (A) a drug which
15 contains any quantity of barbituric acid or any of the salts of
16 barbituric acid; or any derivative of barbituric acid which has
17 been designated by the United States Secretary of Health,
18 Education, and Welfare as habit forming under subsection (d) of
19 section 502 of the "Federal Food, Drug, and Cosmetic Act" (52
20 Stat. 1050; 21 U.S.C. 352 (d)); (B) a drug which contains any
21 quantity of amphetamine or any of its optical isomers; or any
22 salt of amphetamine or any salt of any optical isomer of
23 amphetamine; or any substance which the secretary, after
24 investigation, has found to be, and by regulation designated as,
25 habit forming because of its stimulant effect on the central
26 nervous system; or (C) lysergic acid diethylamide or any other
27 drug which contains any quantity of a substance which the
28 secretary, after investigation, has found to have, and by
29 regulation designates as having, a potential for abuse because
30 of its depressant or stimulant effect on the central nervous
19710H0851B2553 - 5 -
1 system or its hallucinogenic effect; but the term "controlled
2 drug" shall not include any drug specifically exempted by a
3 regulation promulgated by the secretary as not dangerous to the
4 public health and welfare. Except as otherwise provided herein,
5 the term shall include dangerous substances controlled by the
6 secretary under sections 3 and 4 of this act.
7 (15) "Controlled paraphernalia" includes:
8 (i) a hypodermic syringe, needle or other instrument or
9 implement or combination thereof adapted for the administration
10 of controlled dangerous substances by intravenous injections or
11 otherwise under circumstances, including but not limited to, the
12 close proximity to other controlled paraphernalia, which
13 reasonably indicate an intention to use or possess such
14 controlled paraphernalia for purposes of unlawfully
15 administering any controlled dangerous substance;
16 (ii) diluents, dilutants or adulterants, including but not
17 limited to, any of the following: quinine hydrochloride,
18 mannitol, mannite, lactose or dextrose, adapted for the dilution
19 of controlled dangerous substances under circumstances,
20 including, but not limited to, the close proximity to other
21 controlled paraphernalia, which reasonably indicate an intention
22 to use or possess such controlled paraphernalia for purposes of
23 unlawfully diluting or processing any controlled dangerous
24 substance; and
25 (iii) gelatin capsules, glassine envelopes or any other
26 material suitable for the packaging of individual quantities of
27 controlled dangerous substances under circumstances, including
28 but not limited to, the close proximity to other controlled
29 paraphernalia, which reasonably indicate an intention to use or
30 possess any such item for the unlawful manufacture, distribution
19710H0851B2553 - 6 -
1 or dispensing of any such controlled dangerous substance.
2 (16) "Counterfeit drug" means a controlled drug or
3 controlled dangerous substance which, or the container or
4 labeling of which, without authorization, bears the trademark,
5 trade name, or other identifying mark, imprint, number, or
6 device, or any likeness thereof, of a manufacturer, distributor,
7 or dispenser other than the person or persons who in fact
8 manufactured, distributed, or dispensed such substance and which
9 thereby falsely purports or is represented to be the product of,
10 or to have been distributed by, such other manufacturer,
11 distributor, or dispenser.
12 (17) "Dispense" means to transfer or deliver a drug or
13 controlled dangerous substance to an ultimate user or human
14 research subject by, or pursuant to the lawful order of, a
15 practitioner.
16 (18) The term "immediate container" does not include package
17 liners.
18 (19) "Immediate precursor" means a substance which the board
19 has found to be and by regulation designates as being the
20 principal compound commonly used or produced primarily for use,
21 and which is an immediate chemical intermediary used or likely
22 to be used in the manufacture of a controlled dangerous
23 substance, the control of which is necessary to prevent,
24 curtail, or limit such manufacture.
25 (20) "Label" means a display of written, printed or graphic
26 matter upon the immediate container of any article, and a
27 requirement made by or under authority of this act that any
28 word, statement or other information appearing on the label
29 shall not be considered to be complied with unless such word
30 statement or other information also appears on the outside
19710H0851B2553 - 7 -
1 container or wrapper, if any there be, of the retail package of
2 such article or is easily legible through the outside container
3 or wrapper.
4 (21) "Labeling" means all labels and other written, printed,
5 or graphic matter (i) upon an article or any of its containers
6 or wrappers, or (ii) accompanying such article.
7 (22) "Manufacture" means the production, preparation,
8 propagation, compounding, or processing of a drug or controlled
9 dangerous substance, either directly or indirectly by extraction
10 from substances of natural origin, or independently by means of
11 chemical synthesis or by a combination of extraction and
12 chemical synthesis. "Manufacturer" also includes any person who
13 packages, repackages, or labels any container of any drug or
14 controlled dangerous substance, except practitioners who
15 dispense or compound prescription order for delivery to the
16 ultimate consumer.
17 (23) "Marihuana" means all parts of the plant Cannabis,
18 sativa L., whether growing or not; the seeds thereof; the resin
19 extracted from any part of such plant; and every compound,
20 manufacture, salt, derivative, mixture, or preparation of such
21 plant, its seeds, or resin; but shall not include the mature
22 stalks of such plant, fiber produced from such stalks, oil or
23 cake made from the seeds of such plant, any other compound,
24 manufacture, salt, derivative, mixture, or preparation of such
25 mature stalks (except the resin extracted therefrom), fiber,
26 oil, or cake, or the sterilized seeds of such plant which is
27 incapable of germination; and
28 (24) "New drug" means (i) any drug the composition of which
29 is such that such drug is not generally recognized among experts
30 qualified by scientific training and experience to evaluate the
19710H0851B2553 - 8 -
1 safety and effectiveness of drugs as safe and effective for use
2 under the conditions prescribed, recommended or suggested in the
3 labeling thereof; or (ii) any drug the composition of which is
4 such that such drug, as a result of investigations to determine
5 its safety and effectiveness for use under such conditions, has
6 become so recognized, but which has not, otherwise than in such
7 investigations, been used to a material extent or for a material
8 time under such conditions.
9 (25) "Nonproprietary drug" means any drug containing any
10 quantity of any narcotic drug, or controlled dangerous drug or a
11 drug containing biologicals or substances of glandular origin
12 (except intestinal enzymes and all liver products), drugs which
13 are administered hypodermically, intramuscularly or
14 intravenously, but not any such drugs which are prepackaged with
15 complete dosage instructions in the labeling limiting their use
16 to the care or treatment of poultry and livestock.
17 (26) "Official compendium" means the official United States
18 Pharmacopoeia, official Homeopathic Pharmacopoeia of the United
19 States, official National Formulary or any supplement to any of
20 them.
21 (27) "Opiate" means any substance having an addiction-
22 forming or addiction-sustaining liability similar to morphine or
23 being capable of conversion into a drug having such addiction-
24 forming or addiction-sustaining liability.
25 (28) "Opium poppy" means the plant of the species Papaver
26 somniferum L., except the seeds thereof.
27 (29) "Person" means any individual, partnership,
28 corporation, association, trust, or other institution or entity.
29 (30) "Poppy straw" means all parts, except the seeds, of the
30 opium poppy, after mowing.
19710H0851B2553 - 9 -
1 (31) "Possess" means to exercise dominion or control over a
2 drug or controlled dangerous substance.
3 (32) "Practitioner" means a physician, including an intern
4 and resident, dentist, veterinarian, scientific investigator,
5 pharmacist, pharmacy, hospital, clinic, or other person
6 licensed, registered, or otherwise authorized or allowed by the
7 Commonwealth of Pennsylvania to distribute, dispense, conduct
8 research with respect to or administer a drug or controlled
9 dangerous substance in the course of professional practice or
10 research.
11 (33) "Production" includes the manufacture, planting,
12 cultivation, growing, or harvesting of a controlled dangerous
13 substance.
14 (34) "Registrant" means any person registered under the laws
15 of this Commonwealth to manufacture, dispense, administer or
16 sell drugs.
17 (35) "Secretary" means the Secretary of Health of the
18 Commonwealth of Pennsylvania.
19 (36) "Ultimate user" means any person who possesses a drug
20 or controlled dangerous substance for his own use or for the use
21 of a member of his household or for administration to an animal
22 owned by him or by a member of his household.
23 (37) "Wholesaler" means any person engaged in the activities
24 of jobber, dealer, repackager or wholesaler, selling,
25 repackaging or otherwise distributing any drug or controlled
26 dangerous substance for resale or redistribution which he has
27 not himself prepared, produced or compounded.
28 "ADMINISTER" MEANS THE DIRECT APPLICATION OF A CONTROLLED <--
29 SUBSTANCE, OTHER DRUG OR DEVICE, WHETHER BY INJECTION,
30 INHALATION, INGESTION, OR ANY OTHER MEANS, TO THE BODY OF A
19710H0851B2553 - 10 -
1 PATIENT OR RESEARCH SUBJECT.
2 "ADVERTISEMENT" MEANS ANY REPRESENTATION, DISSEMINATED IN ANY
3 MANNER OR BY ANY MEANS OTHER THAN BY LABELING, FOR THE PURPOSE
4 OF INDUCING OR WHICH IS LIKELY TO INDUCE, DIRECTLY OR
5 INDIRECTLY, THE PURCHASE AND/OR USE OF A CONTROLLED SUBSTANCE,
6 OTHER DRUG, DEVICE OR COSMETIC.
7 "AGENT" MEANS AN AUTHORIZED PERSON WHEN ACTING ON BEHALF OF
8 OR AT THE DIRECTION OF A MANUFACTURER, DISTRIBUTOR, OR
9 DISPENSER. IT DOES NOT INCLUDE A COMMON OR CONTRACT CARRIER,
10 PUBLIC WAREHOUSEMAN, OR EMPLOYE OF THE CARRIER OR WAREHOUSEMAN.
11 "BOARD" MEANS THE PENNSYLVANIA DRUG, DEVICE AND COSMETIC
12 BOARD.
13 "BUREAU" MEANS THE BUREAU OF DRUG CONTROL, PENNSYLVANIA
14 DEPARTMENT OF HEALTH.
15 "COLOR ADDITIVE" MEANS A MATERIAL WHICH IS A DYE, PIGMENT OR
16 OTHER SUBSTANCE MADE BY A PROCESS OF SYNTHESIS OR SIMILAR
17 ARTIFICE, OR EXTRACTED, ISOLATED OR OTHERWISE DERIVED, WITH OR
18 WITHOUT INTERMEDIATE OR FINAL CHANGE OF IDENTITY, FROM A
19 VEGETABLE, ANIMAL, MINERAL OR OTHER SOURCE, AND, WHEN ADDED OR
20 APPLIED TO A CONTROLLED SUBSTANCE, OTHER DRUG, DEVICE OR
21 COSMETIC TO THE HUMAN OR ANIMAL BODY, IS CAPABLE, ALONE OR
22 THROUGH REACTION WITH ANOTHER SUBSTANCE, OF IMPARTING COLOR
23 THERETO, EXCEPT THAT SUCH TERM DOES NOT INCLUDE ANY MATERIAL
24 WHICH THE APPROPRIATE AUTHORITY, PURSUANT TO THE FEDERAL ACT,
25 DETERMINES IS USED OR INTENDED TO BE USED SOLELY FOR A PURPOSE
26 OR PURPOSES OTHER THAN COLORING. THE TERM "COLOR" INCLUDES
27 BLACK, WHITE AND INTERMEDIATE GRAYS.
28 "COMMERCIAL CONTAINER" MEANS ANY BOTTLE, JAR, TUBE, AMPUL, OR
29 OTHER RECEPTACLE IN WHICH A CONTROLLED SUBSTANCE, OTHER DRUG,
30 DEVICE OR COSMETIC IS HELD FOR DISTRIBUTION OR DISPENSING TO AN
19710H0851B2553 - 11 -
1 ULTIMATE USER, AND IN ADDITION, ANY BOX OR PACKAGE IN WHICH THE
2 RECEPTACLE IS HELD FOR DISTRIBUTION OR DISPENSING TO AN ULTIMATE
3 USER. THE TERM "COMMERCIAL CONTAINER" DOES NOT INCLUDE ANY
4 PACKAGE LINER, PACKAGE INSERT OR OTHER MATERIAL KEPT WITH OR
5 WITHIN A COMMERCIAL CONTAINER, NOR ANY CARTON, CRATE, DRUG, OR
6 OTHER PACKAGE IN WHICH COMMERCIAL CONTAINERS ARE STORED OR ARE
7 USED FOR SHIPMENT OF CONTROLLED SUBSTANCES.
8 "CONTAMINATED WITH FILTH" MEANS CONSISTING, IN WHOLE OR IN
9 PART, OF ANY DECOMPOSED, PUTRID OR FILTHY SUBSTANCE, OR
10 PREPARED, PACKED OR HELD UNDER ANY UNSANITARY CONDITION OR
11 EXPOSED WHEREBY THE ARTICLE OR PRODUCT CONCERNED MAY HAVE BECOME
12 CONTAMINATED WITH FILTH, DIRT, DUST OR ANY FOREIGN MATERIAL, OR
13 IN ANY MANNER RENDERED INJURIOUS TO HEALTH.
14 "CONTRABAND" MEANS ANY CONTROLLED SUBSTANCE, OTHER DRUG,
15 DEVICE OR COSMETIC POSSESSED BY A PERSON NOT AUTHORIZED BY LAW
16 TO POSSESS SUCH CONTROLLED SUBSTANCE, OTHER DRUG, DEVICE OR
17 COSMETIC, OR OBTAINED OR HELD IN A MANNER CONTRARY TO THE
18 PROVISIONS OF THIS ACT.
19 "CONTROL" MEANS TO REMOVE, OR CHANGE THE PLACEMENT OF A
20 CONTROLLED SUBSTANCE, OR IMMEDIATE PRECURSOR UNDER THE
21 PROVISIONS OF THIS ACT.
22 "CONTROLLED SUBSTANCE" MEANS A DRUG, SUBSTANCE, OR IMMEDIATE
23 PRECURSOR INCLUDED IN SCHEDULES I THROUGH V OF THIS ACT.
24 "COSMETIC" MEANS: (I) SUBSTANCES INTENDED TO BE RUBBED,
25 POURED, SPRINKLED OR SPRAYED ON, INTRODUCED INTO OR OTHERWISE
26 APPLIED TO THE HUMAN BODY OR OTHER ANIMAL BODY OR ANY PART
27 THEREOF FOR CLEANSING, BEAUTIFYING, PROMOTING ATTRACTIVENESS OR
28 ALTERING THE APPEARANCE, AND (II) SUBSTANCES INTENDED FOR USE AS
29 A COMPONENT OF ANY SUCH SUBSTANCES, EXCEPT THAT SUCH TERM SHALL
30 NOT INCLUDE SOAP.
19710H0851B2553 - 12 -
1 "COUNCIL" MEANS THE GOVERNOR'S DRUG AND ALCOHOL ABUSE
2 COUNCIL.
3 "COUNTERFEIT" MEANS A CONTROLLED SUBSTANCE, OTHER DRUG,
4 DEVICE OR COSMETIC WHICH, OR THE CONTAINER OR LABELING OF WHICH,
5 WITHOUT AUTHORIZATION, BEARS THE TRADEMARK, TRADE NAME, OR OTHER
6 IDENTIFYING MARK, IMPRINT, NUMBER, OR DEVICE, OR ANY LIKENESS
7 THEREOF, OF A MANUFACTURER, DISTRIBUTOR, OR DISPENSER OTHER THAN
8 THE PERSON OR PERSONS WHO IN FACT MANUFACTURED, DISTRIBUTED, OR
9 DISPENSED SUCH SUBSTANCE AND WHICH THEREBY IS FALSELY PURPORTED
10 OR REPRESENTED TO BE THE PRODUCT OF, OR TO HAVE BEEN DISTRIBUTED
11 BY, SUCH OTHER MANUFACTURER, DISTRIBUTOR, OR DISPENSER.
12 "COURT" MEANS ALL COURTS OF THE COMMONWEALTH OF PENNSYLVANIA,
13 INCLUDING MAGISTRATES AND JUSTICES OF THE PEACE.
14 "DELIVER" OR "DELIVERY" MEANS THE ACTUAL, CONSTRUCTIVE, OR
15 ATTEMPTED TRANSFER FROM ONE PERSON TO ANOTHER OF A CONTROLLED
16 SUBSTANCE, OTHER DRUG, DEVICE OR COSMETIC WHETHER OR NOT THERE
17 IS AN AGENCY RELATIONSHIP.
18 "DEPARTMENT" MEANS THE DEPARTMENT OF HEALTH OF THE
19 COMMONWEALTH OF PENNSYLVANIA.
20 "DEVICE" MEANS INSTRUMENTS, APPARATUS AND CONTRIVANCES,
21 INCLUDING THEIR COMPONENTS, PARTS AND ACCESSORIES, INTENDED: (I)
22 FOR USE IN THE DIAGNOSIS, CURE, MITIGATION, TREATMENT OR
23 PREVENTION OF DISEASE OF MAN OR OTHER ANIMALS; OR (II) TO AFFECT
24 THE STRUCTURE OR ANY FUNCTION OF THE BODY OF MAN OR OTHER
25 ANIMALS.
26 "DISPENSE" MEANS TO DELIVER A CONTROLLED SUBSTANCE, OTHER
27 DRUG OR DEVICE TO AN ULTIMATE USER OR RESEARCH SUBJECT BY OR
28 PURSUANT TO THE LAWFUL ORDER OF A PRACTITIONER, INCLUDING THE
29 PRESCRIBING, ADMINISTERING, PACKAGING, LABELING, OR COMPOUNDING
30 NECESSARY TO PREPARE SUCH ITEM FOR THAT DELIVERY.
19710H0851B2553 - 13 -
1 "DISPENSER" MEANS A PRACTITIONER WHO DISPENSES.
2 "DISTRIBUTE" MEANS TO DELIVER OTHER THAN BY ADMINISTERING OR
3 DISPENSING A CONTROLLED SUBSTANCE, OTHER DRUG, DEVICE OR
4 COSMETIC.
5 "DISTRIBUTOR" MEANS ANY PERSON ENGAGED IN THE ACTIVITIES OF
6 JOBBER, DEALER, OR WHOLESALER WHO SELLS, OR OTHERWISE
7 DISTRIBUTES, ANY CONTROLLED SUBSTANCE, OTHER DRUG, DEVICE OR
8 COSMETIC FOR RESALE OR REDISTRIBUTION WHICH HE HAS NOT HIMSELF
9 PREPARED, PRODUCED OR COMPOUNDED.
10 "DRUG" MEANS: (I) SUBSTANCES RECOGNIZED IN THE OFFICIAL
11 UNITED STATES PHARMACOPEIA, OR OFFICIAL NATIONAL FORMULARY, OR
12 ANY SUPPLEMENT TO EITHER OF THEM; AND (II) SUBSTANCES INTENDED
13 FOR USE IN THE DIAGNOSIS, CURE, MITIGATION, TREATMENT OR
14 PREVENTION OF DISEASE IN MAN OR OTHER ANIMALS; AND (III)
15 SUBSTANCES (OTHER THAN FOOD) INTENDED TO AFFECT THE STRUCTURE OR
16 ANY FUNCTION OF THE HUMAN BODY OR OTHER ANIMAL BODY; AND (IV)
17 SUBSTANCES INTENDED FOR USE AS A COMPONENT OF ANY ARTICLE
18 SPECIFIED IN CLAUSE (I), (II) OR (III), BUT NOT INCLUDING
19 DEVICES OR THEIR COMPONENTS, PARTS OR ACCESSORIES.
20 "DRUG DEPENDENT PERSON" MEANS A PERSON WHO IS USING A DRUG,
21 CONTROLLED SUBSTANCE OR ALCOHOL, AND WHO IS IN A STATE OF
22 PSYCHIC OR PHYSICAL DEPENDENCE, OR BOTH, ARISING FROM
23 ADMINISTRATION OF THAT DRUG, CONTROLLED SUBSTANCE OR ALCOHOL ON
24 A CONTINUING BASIS. SUCH DEPENDENCE IS CHARACTERIZED BY
25 BEHAVIORAL AND OTHER RESPONSES WHICH INCLUDE A STRONG COMPULSION
26 TO TAKE THE DRUG, CONTROLLED SUBSTANCE OR ALCOHOL ON A
27 CONTINUOUS BASIS IN ORDER TO EXPERIENCE ITS PSYCHIC EFFECTS, OR
28 TO AVOID THE DISCOMFORT OF ITS ABSENCE.
29 "IMMEDIATE PRECURSOR" MEANS A SUBSTANCE WHICH THE SECRETARY
30 HAS FOUND TO BE AND BY REGULATION DESIGNATES AS BEING A
19710H0851B2553 - 14 -
1 PRINCIPAL COMPOUND COMMONLY USED OR PRODUCED PRIMARILY FOR USE,
2 AND WHICH IS AN IMMEDIATE CHEMICAL INTERMEDIARY USED OR LIKELY
3 TO BE USED IN THE MANUFACTURE OF A CONTROLLED SUBSTANCE.
4 "LABEL" MEANS A DISPLAY OF WRITTEN, PRINTED OR GRAPHIC MATTER
5 UPON THE COMMERCIAL CONTAINER OF ANY SUBSTANCE OR ARTICLE AND A
6 REQUIREMENT MADE BY OR UNDER AUTHORITY OF THIS ACT THAT ANY
7 WORD, STATEMENT OR OTHER INFORMATION APPEARING ON THE LABEL
8 SHALL NOT BE CONSIDERED TO BE COMPLIED WITH UNLESS SUCH WORD,
9 STATEMENT OR OTHER INFORMATION ALSO APPEARS ON THE OUTSIDE
10 CONTAINER OR WRAPPER, IF ANY THERE BE, OF THE RETAIL PACKAGE OF
11 SUCH SUBSTANCE OR IS EASILY LEGIBLE THROUGH THE OUTSIDE
12 CONTAINER OR WRAPPER.
13 "LABELING" MEANS ALL LABELS AND OTHER WRITTEN, PRINTED, OR
14 GRAPHIC MATTER: (I) UPON A SUBSTANCE OR ANY OF ITS CONTAINERS OR
15 WRAPPERS; OR (II) ACCOMPANYING SUCH SUBSTANCE.
16 "MANUFACTURE" MEANS THE PRODUCTION, PREPARATION, PROPAGATION,
17 COMPOUNDING, CONVERSION OR PROCESSING OF A CONTROLLED SUBSTANCE,
18 OTHER DRUG OR DEVICE OR THE PACKAGING OR REPACKAGING OF SUCH
19 SUBSTANCE OR ARTICLE, OR THE LABELING OR RELABELING OF THE
20 COMMERCIAL CONTAINER OF SUCH SUBSTANCE OR ARTICLE, BUT DOES NOT
21 INCLUDE THE ACTIVITIES OF A PRACTITIONER WHO, AS AN INCIDENT TO
22 HIS ADMINISTRATION OR DISPENSING SUCH SUBSTANCE OR ARTICLE IN
23 THE COURSE OF HIS PROFESSIONAL PRACTICE, PREPARES, COMPOUNDS,
24 PACKAGES OR LABELS SUCH SUBSTANCE OR ARTICLE. THE TERM
25 "MANUFACTURER" MEANS A PERSON WHO MANUFACTURES A CONTROLLED
26 SUBSTANCE, OTHER DRUG OR DEVICE.
27 "MARIHUANA" MEANS ALL PARTS OF THE PLANT CANNABIS SATIVA L.,
28 WHETHER GROWING OR NOT; THE SEEDS THEREOF; THE RESIN EXTRACTED
29 FROM ANY PART OF SUCH PLANT; AND EVERY COMPOUND, MANUFACTURE,
30 SALT, DERIVATIVE, MIXTURE, OR PREPARATION OF SUCH PLANT, ITS
19710H0851B2553 - 15 -
1 SEEDS OR RESIN; BUT SHALL NOT INCLUDE TETRAHYDROCANNABOL, THE
2 MATURE STALKS OF SUCH PLANT, FIBER PRODUCED FROM SUCH STALKS,
3 OIL OR CAKE MADE FROM THE SEEDS OF SUCH PLANT, ANY OTHER
4 COMPOUND, MANUFACTURE, SALT, DERIVATIVE, MIXTURE, OR PREPARATION
5 OF SUCH MATURE STALKS (EXCEPT THE RESIN EXTRACTED THEREFROM),
6 FIBER, OIL, CAKE, OR THE STERILIZED SEED OF SUCH PLANT WHICH IS
7 INCAPABLE OF GERMINATION.
8 "NARCOTIC" MEANS ANY OF THE FOLLOWING, WHETHER PRODUCED
9 DIRECTLY OR INDIRECTLY BY EXTRACTION FROM SUBSTANCES OF
10 VEGETABLE ORIGIN, OR INDEPENDENTLY BY MEANS OF CHEMICAL
11 SYNTHESIS OR BY A COMBINATION OF EXTRACTION AND CHEMICAL
12 SYNTHESIS: (I) OPIUM, (II) ANY OPIATE HAVING AN ADDICTION-
13 FORMING OR ADDICTION-SUSTAINING CAPACITY SIMILAR TO MORPHINE,
14 BUT NOT INCLUDING THE ISOQUINOLINE ALKALOIDS OF OPIUM, (III) ANY
15 COMPOUND, MANUFACTURE, SALT, DERIVATIVE, OR PREPARATION OF OPIUM
16 OR ANY OPIATE, AND (IV) ANY SUBSTANCE, COMPOUND, MANUFACTURE,
17 SALT, DERIVATIVE, OR PREPARATION THEREOF, WHICH IS CHEMICALLY
18 IDENTICAL WITH ANY OF THE SUBSTANCES REFERRED TO IN (I), (II) OR
19 (III).
20 "NEW DRUG" MEANS (I) ANY DRUG THE COMPOSITION OF WHICH IS
21 SUCH THAT SUCH DRUG IS NOT GENERALLY RECOGNIZED AMONG EXPERTS
22 QUALIFIED BY SCIENTIFIC TRAINING AND EXPERIENCE TO EVALUATE THE
23 SAFETY AND EFFECTIVENESS OF DRUGS AS SAFE AND EFFECTIVE FOR USE
24 UNDER THE CONDITIONS PRESCRIBED, RECOMMENDED OR SUGGESTED IN THE
25 LABELING THEREOF; OR (II) ANY DRUG THE COMPOSITION OF WHICH IS
26 SUCH THAT SUCH DRUG, AS A RESULT OF INVESTIGATIONS TO DETERMINE
27 ITS SAFETY AND EFFECTIVENESS FOR USE UNDER SUCH CONDITIONS, HAS
28 BECOME SO RECOGNIZED, BUT WHICH HAS NOT, OTHERWISE THAN IN SUCH
29 INVESTIGATIONS, BEEN USED TO A MATERIAL EXTENT OR FOR A MATERIAL
30 TIME UNDER SUCH CONDITIONS.
19710H0851B2553 - 16 -
1 "NONPROPRIETARY DRUG" MEANS ANY DRUG CONTAINING ANY QUANTITY
2 OF ANY CONTROLLED SUBSTANCE, A DRUG CONTAINING BIOLOGICALS OR
3 SUBSTANCES OF GLANDULAR ORIGIN (EXCEPT INTESTINAL ENZYMES AND
4 ALL LIVER PRODUCTS), DRUGS WHICH ARE ADMINISTERED PARENTERALLY,
5 BUT NOT ANY SUCH DRUGS WHICH ARE PREPACKAGED WITH COMPLETE
6 DOSAGE INSTRUCTIONS IN THE LABELING LIMITING THEIR USE TO THE
7 CARE OR TREATMENT OF POULTRY AND LIVESTOCK.
8 "OFFICIAL COMPENDIUM" MEANS THE OFFICIAL UNITED STATES
9 PHARMACOPEIA, THE OFFICIAL NATIONAL FORMULARY OR ANY SUPPLEMENT
10 TO EITHER OF THEM.
11 "OPIATE" MEANS ANY SUBSTANCE HAVING AN ADDICTION-FORMING OR
12 ADDICTION-SUSTAINING LIABILITY SIMILAR TO MORPHINE OR BEING
13 CAPABLE OF CONVERSION INTO A DRUG HAVING ADDICTION-FORMING OR
14 ADDICTION-SUSTAINING LIABILITY. IT DOES NOT INCLUDE THE
15 DEXTROROTATORY ISOMER OF 3-METHOXY-N-METHLMORPHINAN AND ITS
16 SALTS (DEXTROMETHORPHAN). IT DOES INCLUDE THE RACEMIC AND
17 LEVOROTATORY FORMS.
18 "OPIUM POPPY" MEANS THE PLANT OF THE SPECIES PAPAVER
19 SOMNIFERUM L., EXCEPT ITS SEEDS.
20 "PERSON" MEANS INDIVIDUAL, CORPORATION, GOVERNMENT OR
21 GOVERNMENTAL SUBDIVISION OR AGENCY, BUSINESS TRUST, ESTATE,
22 TRUST, PARTNERSHIP OR ASSOCIATION, OR ANY OTHER LEGAL ENTITY.
23 "POPPY STRAW" MEANS ALL PARTS, EXCEPT THE SEEDS, OF THE OPIUM
24 POPPY, AFTER MOWING.
25 "PRACTITIONER" MEANS: (I) A PHYSICIAN, OSTEOPATH, DENTIST,
26 VETERINARIAN, PHARMACIST, PODIATRIST, NURSE, SCIENTIFIC
27 INVESTIGATOR, OR OTHER PERSON LICENSED, REGISTERED OR OTHERWISE
28 PERMITTED TO DISTRIBUTE, DISPENSE, CONDUCT RESEARCH WITH RESPECT
29 TO OR TO ADMINISTER A CONTROLLED SUBSTANCE, OTHER DRUG OR DEVICE
30 IN THE COURSE OF PROFESSIONAL PRACTICE OR RESEARCH IN THE
19710H0851B2553 - 17 -
1 COMMONWEALTH OF PENNSYLVANIA; (II) A PHARMACY, HOSPITAL, CLINIC
2 OR OTHER INSTITUTION LICENSED, REGISTERED, OR OTHERWISE
3 PERMITTED TO DISTRIBUTE, DISPENSE, CONDUCT RESEARCH WITH RESPECT
4 TO OR TO ADMINISTER A CONTROLLED SUBSTANCE, OTHER DRUG OR DEVICE
5 IN THE COURSE OF PROFESSIONAL PRACTICE OR RESEARCH IN THE
6 COMMONWEALTH OF PENNSYLVANIA.
7 "PRODUCTION" INCLUDES THE MANUFACTURE, PLANTING, CULTIVATION,
8 GROWING OR HARVESTING OF A CONTROLLED SUBSTANCE, OTHER DRUG,
9 DEVICE AND COSMETIC.
10 "PRESCRIPTION" OR "PRESCRIPTION ORDER" MEANS AN ORDER FOR A
11 CONTROLLED SUBSTANCE, OTHER DRUG OR DEVICE FOR MEDICATION WHICH
12 IS DISPENSED TO OR FOR AN ULTIMATE USER BUT DOES NOT INCLUDE AN
13 ORDER FOR A CONTROLLED SUBSTANCE, OTHER DRUG OR DEVICE FOR
14 MEDICATION WHICH IS DISPENSED FOR IMMEDIATE ADMINISTRATION TO
15 THE ULTIMATE USER. (E.G., AN ORDER TO DISPENSE A DRUG TO A BED
16 PATIENT FOR IMMEDIATE ADMINISTRATION IN A HOSPITAL IS NOT A
17 PRESCRIPTION ORDER.)
18 "REGISTRANT" MEANS ANY ONE PERSON REGISTERED UNDER THE LAWS
19 OF THIS COMMONWEALTH TO MANUFACTURE, DISPENSE, DISTRIBUTE,
20 ADMINISTER OR SELL DRUGS.
21 "SECRETARY" MEANS THE SECRETARY OF HEALTH OF THE COMMONWEALTH
22 OF PENNSYLVANIA.
23 "ULTIMATE USER" MEANS A PERSON WHO LAWFULLY POSSESSES A
24 CONTROLLED SUBSTANCE, OTHER DRUG, DEVICE OR COSMETIC FOR HIS OWN
25 USE OR FOR THE USE OF A MEMBER OF HIS HOUSEHOLD OR FOR
26 ADMINISTERING TO AN ANIMAL IN HIS CARE.
27 Section 3. Authority to Control.--(a) The secretary shall
28 control all substances enumerated in section 4 LISTED IN <--
29 SCHEDULES I THROUGH V of this act and may, by regulation, upon
30 his own motion or on the petition of any interested party add,
19710H0851B2553 - 18 -
1 delete, or reschedule a substance as a controlled dangerous <--
2 substance. Such regulations shall be adopted in accordance with
3 the act of July 31, 1968 (Act No. 240), known as the
4 "Commonwealth Documents Law." Before so doing, the secretary
5 shall request the advice in writing from the board whether a
6 substance should be added, deleted, or rescheduled as a
7 controlled dangerous substance. Such advice shall be rendered to <--
8 the secretary within a reasonable time. The secretary shall
9 consider with respect to each substance hereafter controlled:
10 (1) Its actual or relative potential for abuse;
11 (2) Scientific evidence of its pharmacological effect, if
12 known;
13 (3) State of current scientific knowledge regarding the
14 substance;
15 (4) Its history and current pattern of abuse;
16 (5) The scope, duration, and significance of abuse;
17 (6) What, if any, THE risk there is to the public health; <--
18 (7) Its psychic or physiological dependence liability;
19 (8) Whether the substance is controlled under Federal law;
20 and
21 (9) Whether the substance is an immediate precursor of a
22 substance already controlled under this section. After
23 considering the above factors, the secretary shall make findings
24 with respect thereto and shall issue an order A REGULATION <--
25 controlling the substance if he finds that the substance has a
26 potential for abuse.
27 (b) If the secretary designates a substance as an immediate
28 precursor, substances which are precursors of the controlled
29 precursor shall not be subject to control solely because they
30 are precursors of the controlled precursor.
19710H0851B2553 - 19 -
1 (c) When, for the purpose of greater protection of the <--
2 public, at the time a new drug application is submitted to the
3 board for any drug having a stimulant, depressant, or
4 hallucinogenic effect on the central nervous system, it appears
5 that such drug has an abuse potential such information shall be
6 submitted to review by the Scientific Advisory Committee of the
7 Board prior to their advising the secretary whether or not to
8 control such drug under this act.
9 (d) (C) The secretary shall not remove any Schedule I <--
10 substance of section 4 of this act to Schedules II, III, IV or V <--
11 of such section, nor shall he delete such substances from the
12 controls of this act unless specifically authorized by the
13 General Assembly BOARD to do so. <--
14 Section 4. Schedules of Controlled Dangerous Substances.-- <--
15 The following schedules include the controlled dangerous <--
16 substances listed or to be listed by whatever official name,
17 common or usual name, chemical name, or trade name designated.
18 (1) Schedule I--In determining that a substance comes within
19 this schedule, the secretary shall find: a high potential for
20 abuse, no currently accepted medical use in the United States,
21 and a lack of accepted safety for use under medical supervision.
22 The following controlled dangerous substances are included in <--
23 this schedule:
24 (i) Any of the following opiates, including their isomers,
25 esters, ethers, salts, and salts of isomers, esters, and ethers,
26 unless specifically excepted, whenever the existence of such
27 isomers, esters, ethers and salts is possible within the
28 specific chemical designation:
29 1. Acetylmethadol.
30 2. Allylprodine.
19710H0851B2553 - 20 -
1 3. Alphacteylmethadol. ALPHACETYLMETHADOL. <--
2 4. Alphameprodine.
3 5. Alphamethadol.
4 6. Benzethidine.
5 7. Betacetylmethadol.
6 8. Betameprodine.
7 9. Betamethadol.
8 10. Betaprodine.
9 11. Clonitazene.
10 12. Dextromoramide.
11 13. Dextrorphan (except its methylether).
12 14. Diampromide.
13 15. Diethyliambutene. DIETHYLTHIAMBUTENE. <--
14 16. Dimenoxadol.
15 17. Dimepheptanol.
16 18. Dimethyliambutene. DIMETHYLTHIAMBUTENE. <--
17 19. Dioxaphetyl butyrate.
18 20. Dipipanone.
19 21. Ethylmethylthiambutene.
20 22. Etonitazene.
21 23. Etoxeridine.
22 24. Furethidine.
23 25. Hydroxypethidine.
24 26. Ketobemidone.
25 27. Levomoramide.
26 28. Levophenacylmorphan.
27 29. Morpheridine.
28 30. Noracymethadol.
29 31. Norlevorphanol.
30 32. Normethadone.
19710H0851B2553 - 21 -
1 33. Norpipanone.
2 34. Phenadoxone.
3 35. Phenampromide.
4 36. Phenomorphan.
5 37. Phenoperidine.
6 38. Piritramide.
7 39. Proheptazine.
8 40. Properidine.
9 41. Racemoramide.
10 42. Trimeperidine.
11 (ii) Any of the following opium derivatives, their salts,
12 isomers and salts of isomers, unless specifically excepted,
13 whenever the existence of such salts, isomers and salts of
14 isomers is possible within the specific chemical designation:
15 1. Acetorphine.
16 2. Acetyldihydrocodeine.
17 3. Benzylmorphine.
18 4. Codeine Methylbromide. METHYLBROMIDE. <--
19 5. Codeine-N-Oxide.
20 6. Cyprenorphine.
21 7. Desomorphine.
22 8. Dihydromorphine.
23 9. Etorphine.
24 10. Heroin.
25 11. Hydromorphinol.
26 12. Methyldesorphine.
27 13. Methylhydromorphine.
28 14. Morphine methylbromide.
29 15. Morphine methylsulfonate.
30 16. Morphine-N-Oxide.
19710H0851B2553 - 22 -
1 17. Myrophine.
2 18. Nicocodeine.
3 19. Nicomorphine.
4 20. Normorphine.
5 21. Pholcodine.
6 22. Thebacon.
7 (iii) Any material, compound, mixture, or preparation which
8 contains any quantity of the following hallucinogenic
9 substances, their salts, isomers, and salts of isomers, unless
10 specifically excepted, whenever the existence of such salts,
11 isomers, and salts of isomers is possible within the specific
12 chemical designation:
13 1. 3,4-methylenedioxy amphetamine.
14 2. 5-methoxy-3,4-methylenedioxy amphetamine.
15 3. 3,4,5-trimethoxy amphetamine.
16 4. Bufotenine.
17 5. Diethyltryptamine.
18 6. Dimethyltryptamine.
19 7. 4-methyl-2,5-dimethoxyamphetamine.
20 8. Ibogaine.
21 9. Lysergic acid diethylamide.
22 10. Marihuana. <--
23 11. 10. Mescaline. <--
24 12. 11. Peyote. <--
25 13. 12. N-ethyl-3-piperidyl benzilate. <--
26 14. 13. N-methyl-3-piperidyl benzilate. <--
27 15. 14. Psilocybin. <--
28 16. 15. Psilocyn. <--
29 17. Tetrahydrocannabinois. 16. TETRAHYDROCANNABINOLS. <--
30 (IV) MARIHUANA. <--
19710H0851B2553 - 23 -
1 (2) Schedule II--In determining that a substance comes
2 within this schedule, the secretary shall find: a high potential
3 for abuse, currently accepted medical use in the United States,
4 or currently accepted medical use with severe restrictions, and
5 abuse may lead to severe psychic or physical dependence. The
6 following controlled dangerous substances are included in this <--
7 schedule:
8 (i) Any of the following substances except those narcotic <--
9 drugs NARCOTICS specifically excepted or listed in other <--
10 schedules, whether produced directly or indirectly by extraction
11 from substances of vegetable origin, or independently by means
12 of chemical synthesis, or by combination of extraction and
13 chemical synthesis:
14 1. Opium and opiate, and any salt, compound, derivative, or
15 preparation of opium or opiate.
16 2. Any salt, compound, derivative, or preparation thereof
17 which is chemically equivalent or identical with any of the
18 substances referred to in subclause 1, except that these
19 substances shall not include the isoquinoline alkaloids of
20 opium.
21 3. Opium poppy and poppy straw.
22 4. Coca leaves and any salt, compound, derivative, or
23 preparation of coca leaves, and any salt, compound, derivative,
24 or preparation thereof which is chemically equivalent or
25 identical with any of these substances, except that the <--
26 substances BUT shall not include decocainized coca leaves or <--
27 extraction EXTRACTS of coca leaves, which extractions EXTRACTS <--
28 do not contain cocaine or ecgonine.
29 (ii) Any of the following opiates, including their isomers,
30 esters, ethers, salts, and salts of isomers, esters and ethers,
19710H0851B2553 - 24 -
1 unless specifically excepted OR LISTED IN ANOTHER SCHEDULE, <--
2 whenever the existence of such isomers, esters, ethers and salts
3 is possible within the specific chemical designation:
4 1. Alphaprodine.
5 2. Anileridine.
6 3. Bezitramide.
7 4. Dihydrocodeine.
8 5. Diphenoxylate.
9 6. Fentanyl.
10 7. Isomethadone.
11 8. Levomethorphan.
12 9. Levorphanol.
13 10. Metazocine.
14 11. Methadone.
15 12. Methadone-Intermediate, 4-cyano-2-dimethylamino-4,4-
16 diphenyl butane.
17 13. Moramide-Intermediate, 2-methyl-3-morpholino-1, 1-
18 diphenyl-propane-carboxylic acid.
19 14. PENTAZOCENE <--
20 14. PENTAZOCINE <--
21 14. 15. 14. Pethidine. <--
22 15. 16. 15. Pethidine-Intermediate-A, 4-cyano-1-methyl-4- <--
23 phenylpiperidine.
24 16. 17. 16. Pethidine-Intermediate-B, ethyl-4- <--
25 phenylpiperidine-4-carboxylate.
26 17. 18. 17. Pethidine-Intermediate-C, 1-methyl-4- <--
27 phenylpiperidine-4-carboxylic acid.
28 18. 19. 18. Phenazocine. <--
29 19. 20. 19. Piminodine. <--
30 20. 21. 20. Racemethorphan. <--
19710H0851B2553 - 25 -
1 21. 22. 21. Racemorphan. <--
2 (iii) Unless specifically excepted or unless listed in
3 another schedule, any injectable liquid MATERIAL, COMPOUND, <--
4 MIXTURE OR PREPARATION which contains any quantity of
5 methamphetamine, including its salts, isomers, and salts of <--
6 isomers THE FOLLOWING SUBSTANCES, HAVING A POTENTIAL FOR ABUSE <--
7 ASSOCIATED WITH THE STIMULANT EFFECT ON THE CENTRAL NERVOUS
8 SYSTEM:
9 1. AMPHETAMINE, ITS SALTS, OPTICAL ISOMERS, AND SALTS OF ITS
10 OPTICAL ISOMERS.
11 2. PHENMETRAMINE AND ITS SALTS.
12 3. METHYLPHENIDATE.
13 4. ANY SUBSTANCE WHICH CONTAINS ANY QUANTITY OF
14 METHAMPHETAMINE INCLUDING ITS SALTS, ISOMERS AND SALTS OF
15 ISOMERS.
16 (iv) The phrase "opiates" as used in section 4 of this act
17 and elsewhere throughout the act shall not include the
18 dextrorotatory isomer of 3-methoxy-n-methylmorphinan and its
19 salts, but does include its racemic and levorotatory forms.
20 (3) Schedule III--In determining that a substance comes
21 within this schedule, the secretary shall find: a potential for
22 abuse less than the substances listed in Schedules I and II;
23 well documented and currently accepted medical use in the United
24 States; and abuse may lead to moderate or low physical
25 dependence or high psychological dependence. The following
26 classes of controlled dangerous substances are included in this <--
27 schedule:
28 (i) Any material, compound, mixture, or preparation unless <--
29 specifically excepted or unless listed in another schedule which
30 contains any quantity of the following substances having a
19710H0851B2553 - 26 -
1 potential for abuse associated with a stimulant effect on the
2 central nervous system:
3 1. Amphetamine, its salts, optical isomers, and salts of its
4 optical isomers.
5 2. Phenmetrazine and its salts.
6 3. Any substance which contains any quantity of
7 methamphetamine, including its salts, isomers, and salts of
8 isomers.
9 4. Methylphenidate.
10 (ii) (I) Any material, compound, mixture, or preparation <--
11 unless specifically excepted or unless listed in another
12 schedule which contains any quantity of the following substances
13 having a potential for abuse associated with a depressant effect
14 on the central nervous system:
15 1. Any substance which contains any quantity of a derivative
16 of barbituric acid, or any salt of a derivative of barbituric
17 acid.
18 2. Chorhexadol.
19 3. Glutethimide.
20 4. Lysergic acid.
21 5. Lysergic acid amide.
22 6. Methyprylon.
23 7. Phencyclidine.
24 8. Sulfondiethylmethane.
25 9. Sulfonethylmethane.
26 10. Sulfonmethane.
27 (iii) (II) Nalorphine. <--
28 (iv) (III) Any material, compound, mixture, or preparation <--
29 containing limited quantities of any of the following narcotic <--
30 drugs, or any salts thereof, except those narcotic drugs UNLESS <--
19710H0851B2553 - 27 -
1 specifically excepted or listed in other schedules:
2 1. Not more than one and eighty one-hundredths 1.8 grams of <--
3 codeine per one hundred 100 milliliters or not more than ninety <--
4 90 milligrams per dosage unit, with an equal or greater quantity
5 of an isoquinoline alkaloid of opium.
6 2. Not more than one and eighty one-hundredths 1.8 grams of <--
7 codeine per one hundred 100 milliliters or not more than ninety <--
8 90 milligrams per dosage unit, with one or more active,
9 nonnarcotic ingredients in recognized therapeutic amounts.
10 3. Not more than three hundred 300 milligrams of <--
11 dihydrocodeinone per one hundred 100 milliliters or not more <--
12 than fifteen 15 milligrams per dosage unit, with a fourfold or <--
13 greater quantity of an isoquinoline alkaloid of opium.
14 4. Not more than three hundred 300 milligrams of <--
15 dihydrocodeinone per one hundred 100 milliliters or not more <--
16 than fifteen 15 milligrams per dosage unit, with one or more <--
17 active, nonnarcotic ingredients in recognized therapeutic
18 amounts.
19 5. Not more than one and eighty one-hundredths 1.8 grams of <--
20 dihydrocodeine per one hundred 100 milliliters or not more than <--
21 ninety 90 milligrams per dosage unit, with one or more active, <--
22 nonnarcotic ingredients in recognized therapeutic amounts.
23 6. Not more than three hundred 300 milligrams of <--
24 ethylmorphine per one hundred 100 milliliters or not more than <--
25 fifteen 15 milligrams per dosage unit, with one or more active, <--
26 nonnarcotic ingredients in recognized therapeutic amounts.
27 7. Not more than five hundred 500 milligrams of opium per <--
28 one hundred 100 milliliters or per hundred 100 grams, or not <--
29 more than twenty-five 25 milligrams per dosage unit, with one or <--
30 more active, nonnarcotic ingredients in recognized therapeutic
19710H0851B2553 - 28 -
1 amounts.
2 8. Not more than fifty 50 milligrams of morphine per one <--
3 hundred 100 milliliters or per one hundred grams 100 GRAMS AND <--
4 NOT MORE THAN 2.5 MILLIGRAMS PER DOSAGE UNIT with one or more
5 active, nonnarcotic ingredients in recognized therapeutic
6 amounts.
7 (v) The secretary may by regulation except any compound,
8 mixture, or preparation containing any drug or controlled
9 dangerous substance listed in subclauses (i) and (ii) of this <--
10 schedule above from the application of those provisions of this
11 act covering controlled drugs, SUBSTANCES, if the compound, <--
12 mixture, or preparation contains one or more active medicinal
13 ingredients not having a stimulant or depressant effect on the
14 central nervous system: Provided, That such admixtures shall be
15 included therein in such combinations, quantity, proportion, or
16 concentration as to vitiate the potential for abuse of the
17 substances which do have a stimulant or depressant effect on the
18 central nervous system.
19 (vi) The secretary shall MAY SHALL by regulation exempt any <--
20 nonnarcotic substance from the control under this act if such
21 substance may, under the provisions of the Federal Food, Drug,
22 and Cosmetic Act (21 U.S.C. 301 et seq.), be lawfully sold over
23 the counter without a prescription.
24 (4) Schedule IV--In determining that a substance comes
25 within this schedule, the secretary shall find: a low potential
26 for abuse relative to substances in Schedule III; currently
27 accepted medical use in treatment in the United States; and <--
28 limited physical dependence and/or psychological dependence <--
29 liability relative to the substances listed in Schedule III. The
30 following controlled dangerous substances are included in this <--
19710H0851B2553 - 29 -
1 schedule:
2 (i) Any material, compound, mixture, or preparation, unless
3 specifically excepted or unless listed in another schedule,
4 which contains any quantity of the following substances having a
5 potential for abuse associated with a depressant effect on the
6 central nervous system:
7 1. Barbital.
8 2. CHLORDIAZEPOXIDE. <--
9 2. 3. 2. Chloral betaine. <--
10 3. 4. 3. Chloral hydrate. <--
11 5. DIAZEPON. <--
12 4. 6. 4. Ethchlorvynol. <--
13 5. 7. 5. Ethinamate. <--
14 6. 8. 6. Methohexital. <--
15 7. 9. 7. Meprobamate. <--
16 8. 10. 8. Methylphenobarbital. <--
17 9. 11. 9. Paraldehyde. <--
18 10. 12. 10. Petrichloral. <--
19 11. 13. 11. Phenobarbital. <--
20 14. PROPOXYPHENE. <--
21 (ii) The secretary may by regulation except any compound,
22 mixture, or preparation containing any drug or controlled
23 dangerous substance listed in subclause (i) of this schedule
24 above from the application of those provisions of this act
25 covering controlled drugs, if the compound, mixture, or
26 preparation contains one or more active medicinal ingredients
27 not having a stimulant or depressant effect on the central
28 nervous system: Provided, That such admixtures shall be included
29 therein in such combinations, quantity, proportion, or
30 concentration as to vitiate the potential for abuse of the
19710H0851B2553 - 30 -
1 substances which do have a stimulant or depressant effect on the
2 central nervous system.
3 (iii) The secretary shall MAY SHALL by regulation exempt any <--
4 nonnarcotic substance from the control under this act if such
5 substance may, under the provisions of the Federal Food, Drug,
6 and Cosmetic Act (21 U.S.C. 301 et seq.), be lawfully sold over
7 the counter without a prescription.
8 (5) Schedule V--In determining that a substance comes within
9 this schedule, the secretary shall find: a low potential for
10 abuse relative to the substances listed in Schedule IV;
11 currently accepted medical use in the United States; and limited
12 physical dependence and/or psychological dependence liability
13 relative to the substances listed in Schedule IV. The following
14 controlled dangerous substances are included in this schedule: <--
15 (i) Any compound, mixture, or preparation containing limited
16 quantities of any of the following narcotic drugs NARCOTICS OR <--
17 ANY OF THEIR SALTS, which shall include one or more nonnarcotic
18 active medicinal ingredients in sufficient proportion to confer
19 upon the compound, mixture, or preparation, valuable medicinal
20 qualities other than those possessed by the narcotic drug alone: <--
21 1. Not more than two hundred 200 milligrams of codeine, per <--
22 one hundred OR ANY OF ITS SALTS, PER 100 milliliter or per one <--
23 hundred grams 100 GRAMS AND NOT MORE THAN 100 10 MILLIGRAMS PER <--
24 DOSAGE UNIT.
25 2. Not more than one hundred 100 milligrams of <--
26 dihydrocodeine, OR ANY OF ITS SALTS, per one hundred 100 <--
27 milliliters or per one hundred 100 grams AND NOT MORE THAN 5 <--
28 MILLIGRAMS PER DOSAGE UNIT.
29 3. Not more than one hundred 100 milligrams of ethylmorphine <--
30 per one hundred milliliters or per one hundred grams.
19710H0851B2553 - 31 -
1 ETHYLMORPHINE, OR ANY OF ITS SALTS, PER 100 MILLILITERS OR PER <--
2 100 GRAMS AND NOT MORE THAN 5 MILLIGRAMS PER DOSAGE UNIT.
3 4. Not more than two and five-tenths 2.5 milligrams of <--
4 diphenoxylate and not less than twenty-five 25 micrograms of <--
5 atropine sulfate per dosage unit.
6 5. Not more than one hundred 100 milligrams of opium per one <--
7 hundred 100 milliliters or per one hundred 100 grams, or not <--
8 more than five 5 milligrams per dosage unit. <--
9 Section 5. Exempt Substances and Drugs.--(a) In accordance <--
10 with the provisions of section 3, the secretary, after
11 consultation and upon the recommendation of the board, may, by
12 regulation, exempt, from the provisions of this act relating to
13 controlled dangerous substances or controlled drugs to such
14 extent as he determines to be consistent with the public
15 welfare, substances and drugs found by the secretary:
16 (1) Either to possess no addiction-forming or addiction-
17 sustaining liability or not to possess an addiction-forming or
18 addiction-sustaining liability sufficient to warrant imposition
19 of all of the requirements of this act; and
20 (2) Not to permit recovery of a controlled dangerous
21 substance or controlled drug having such an addiction-forming or
22 addiction-sustaining liability with such relative technical
23 simplicity and degree of yield as to create a risk of improper
24 use.
25 (b) In exercising the authority granted in subsection (a),
26 the secretary, by regulations and without special findings,
27 shall, unless cogent reasons require otherwise in the interest
28 of public health, grant exempt status to such substances and
29 drugs as are determined to be exempt under the Federal narcotic
30 law and regulations and the Federal law and regulations
19710H0851B2553 - 32 -
1 pertaining to controlled drugs and controlled dangerous
2 substances.
3 (c) If the secretary shall subsequently determine that any
4 exempt substance or drug does possess a degree of addiction
5 liability that results in abusive use, he shall, by regulation,
6 remove such substance or drug from exempt status effective on a
7 date fixed by the regulation.
8 SECTION 5. EXEMPT CONTROLLED SUBSTANCES, OTHER DRUGS, <--
9 DEVICES AND COSMETICS.--(A) EXCEPT AS OTHERWISE PROVIDED HEREIN,
10 THE SECRETARY, AFTER CONSULTATION WITH AND UPON THE
11 RECOMMENDATION OF THE BOARD, MAY, BY REGULATION, EXEMPT FROM THE
12 PROVISIONS OF THIS ACT RELATING TO CONTROLLED SUBSTANCES, OTHER
13 DRUGS, DEVICES AND COSMETICS TO SUCH EXTENT AS HE DETERMINES TO
14 BE CONSISTENT WITH THE PUBLIC HEALTH.
15 Section 6. Registration.--(a) No person shall operate within
16 this Commonwealth as a manufacturer, wholesaler DISTRIBUTOR or <--
17 retailer of drugs or CONTROLLED SUBSTANCES, OTHER DRUGS AND <--
18 devices nor sell, offer for sale nor solicit the purchase of
19 drugs or devices nor hold drugs or devices CONTROLLED <--
20 SUBSTANCES, OTHER DRUGS AND DEVICES NOR HOLD THEM for sale or
21 resale until such person has registered under this act with the
22 secretary. Such registration must be renewed annually in
23 accordance with rules and regulations relating thereto.
24 (1) Any manufacturer or wholesaler DISTRIBUTOR not operating <--
25 an establishment within this Commonwealth, but employing sales
26 representatives or detailmen AGENTS within this Commonwealth, <--
27 shall either register as a manufacturer or wholesaler <--
28 DISTRIBUTOR as the case may be, or file, in lieu of <--
29 registration, with the secretary the names and addresses of such
30 representatives and detailmen AGENTS, and shall promptly inform <--
19710H0851B2553 - 33 -
1 the secretary of any changes in said list.
2 (2) Separate registration with the secretary shall be
3 required annually for each place at which such person carries on
4 activities as a manufacturer, wholesaler DISTRIBUTOR or retailer <--
5 within this Commonwealth. The certificate evidencing such
6 registration shall be conspicuously displayed and shall not be
7 transferable.
8 (3) Certificates of registration REGISTRATIONS issued by the <--
9 State Board of Pharmacy SECRETARY or under the law preceding <--
10 this act to manufacturers, DISTRIBUTORS OR RETAILERS shall <--
11 continue to be valid for the period issued and, upon expiration,
12 shall be renewed in the manner provided for renewal of <--
13 certificates of registration issued pursuant to this section.
14 Nothing contained herein shall be construed to require the
15 registration hereunder of pharmacists registered by the Board of <--
16 Pharmacy nor pharmacies licensed by said board, ANY PRACTITIONER <--
17 REGISTERED OR LICENSED BY THE APPROPRIATE STATE BOARD, nor to
18 require the separate registration of agents or employes of
19 persons registered pursuant to the provisions of this section,
20 or of sales representatives or detailmen AGENTS of manufacturers <--
21 or wholesalers nor DISTRIBUTORS NOT operating an establishment <--
22 within this Commonwealth whose names and addresses are on file
23 with the secretary: Provided, however, That all persons
24 registered pursuant to this section, whether located within this
25 Commonwealth or not, shall be deemed to have accepted and shall
26 be subject to all provisions of this act.
27 (b) No person shall operate as a manufacturer of CONTROLLED <--
28 SUBSTANCES OR OTHER drugs or devices unless such drugs or <--
29 devices THEY are manufactured under the supervision of a <--
30 registered pharmacist, chemist or other person possessing at
19710H0851B2553 - 34 -
1 least five years' experience in the manufacture of CONTROLLED <--
2 SUBSTANCES, OR OTHER drugs or devices or such other person <--
3 approved by the secretary as qualified by scientific or
4 technical training or experience to perform such duties of
5 supervision as may be necessary to protect the public health and
6 safety.
7 (c) Each application for registration as a manufacturer
8 shall be accompanied by a fee of one hundred dollars ($100).
9 Each application for registration as a wholesaler DISTRIBUTOR <--
10 shall be accompanied by a fee of twenty-five dollars ($25). Each
11 application for registration as a retailer shall be accompanied
12 by a fee of two dollars ($2). Applications shall be on forms
13 prescribed by the secretary. Registration certificates shall be <--
14 renewed annually and applications therefor shall be accompanied
15 by the same fee as for initial applications.
16 (d) Registration INITIAL REGISTRATION shall become effective <--
17 at noon on the sixtieth day after application therefor is filed:
18 Provided, however, That the secretary shall have authority to
19 issue a registration certificate or to issue an order denying <--
20 such registration pursuant to subsection (e) hereof at any time
21 prior to the expiration of such sixty day period. Renewal of
22 registration shall be effective upon certification by the
23 secretary that the applicant has met all requirements for such
24 renewal.
25 (e) The secretary may refuse the initial registration OR AND <--
26 MAY, AFTER NOTICE AND HEARING PURSUANT TO THE ADMINISTRATIVE
27 AGENCY LAW, SUSPEND REGISTRATION (i) of any person who has made
28 MATERIAL false representation in the application for <--
29 registration; or of any person or agent or employe of any person <--
30 who manufactures drugs or devices other than under the
19710H0851B2553 - 35 -
1 supervision of a registered pharmacist, chemist or other person
2 possessing at least five years' experience in the manufacture of
3 said drugs or devices, or such person approved by the secretary
4 as provided herein, or who fails to comply with the standards of
5 sanitation, equipment, materials or supplies promulgated
6 pursuant to the provisions of this act, until such person has
7 filed a proper application and is in compliance with this
8 section and with said standards of sanitation, equipment,
9 materials and supplies; and (ii) in addition to the foregoing,
10 of (II) any manufacturer or wholesaler, (A) DISTRIBUTOR OR ANY <--
11 EMPLOYE THEREOF who has been convicted of a violation of any law
12 of this Commonwealth or of the United States relating to the
13 sale, use or possession of controlled drugs SUBSTANCES OR OTHER <--
14 DRUGS OR DEVICES if such refusal shall be necessary for the
15 protection of the public health and safety. or (B) who knowingly <--
16 employs in any capacity connected with the preparation, handling
17 or sale of controlled drugs any person convicted of a violation
18 of the laws of this Commonwealth or of the United States
19 relating to the sale, use or possession of narcotics, unless
20 prior consent shall have been obtained from the secretary.
21 (f) In addition to all other penalties provided for <--
22 violations of this act, the THE secretary may, after notice and <--
23 hearing pursuant to the Administrative Agency Law as amended,
24 (i) in the case of a manufacturer registered hereunder, prohibit <--
25 the sale in Pennsylvania of any CONTROLLED SUBSTANCES, OTHER <--
26 drugs or devices involved in any violation of this act. which he <--
27 commits with knowledge or reason to know of said violation, (ii)
28 THE SECRETARY MAY AFTER NOTICE AND HEARING PURSUANT TO THE <--
29 ADMINISTRATIVE AGENCY LAW suspend or revoke the registration of
30 any manufacturer if said registrant, WHO (A) makes any sale in <--
19710H0851B2553 - 36 -
1 Pennsylvania of any CONTROLLED SUBSTANCES, OTHER drug or device <--
2 DRUGS OR DEVICES whose sale has been prohibited under the <--
3 preceding clause. or (B) is convicted of a violation of any law <--
4 of this Commonwealth or of the United States relating to the
5 sale, use or possession of drugs or controlled substances if
6 such suspension or revocation shall be necessary for the
7 protection of the public health and safety, (C) knowingly
8 employs in any capacity connected with the preparation, handling
9 or sale of drugs or controlled substances any person convicted
10 of a violation of the laws of this Commonwealth or of the United
11 States relating to the sale, use or possession of drugs or
12 controlled substances unless prior consent shall have been
13 obtained from the secretary, (iii) in the case of a wholesaler
14 registered hereunder, suspend or revoke his registration for any
15 violation of this act which he commits with knowledge or reason
16 to know of said violation if such suspension or revocation shall
17 be necessary for the protection of the public health and safety.
18 (g) If the secretary takes any action refusing registration
19 or disciplining any registrant REVOKING OR SUSPENDING <--
20 REGISTRATION under subsections (e) and (f), the aggrieved party
21 may, within fifteen days after the date upon which a copy of the
22 order is delivered to the address indicated on the application
23 or the registration certificate, whichever is applicable, <--
24 petition the board for review. The board shall, within thirty
25 days, grant a hearing and, as soon thereafter as practicable,
26 adopt, modify or reject the action of the secretary. Any action
27 by the board shall be deemed an adjudication to which the
28 provisions of the Administrative Agency Law, as amended, shall
29 be applicable.
30 Section 7. Adulteration.--A CONTROLLED SUBSTANCE, OTHER <--
19710H0851B2553 - 37 -
1 drug, or device or cosmetic shall be deemed to be adulterated: <--
2 (1) (i) If it consists, in whole or in part, of any filthy,
3 putrid or decomposed substance; (ii) if it has been prepared,
4 packed or held under UNSANITARY conditions whereby it may have <--
5 been contaminated with filth, or whereby it may have been
6 rendered injurious to health; (iii) if AND IF IT IS A DRUG OR A <--
7 DEVICE its container is composed, in whole or in part, of any
8 poisonous or deleterious substance which may render the contents
9 injurious to health; (iv) if it has been exposed to conditions
10 of fire, water or extreme temperature, which may have rendered
11 it injurious to health; (v) if (A) it bears or contains for
12 purposes of coloring only a color additive, unless it be a hair
13 dye which is unsafe within the meaning of section 9 of this act,
14 or (B) it is a color additive the intended use of which in or on
15 drugs, devices or cosmetics is for purposes of coloring only and
16 is unsafe, unless it be a hair dye within the meaning of section
17 9 of this act.
18 (2) If it purports to be or is represented as a drug OR <--
19 DEVICE, the name of which is recognized in an official
20 compendium and its strength differs from or its quality or
21 purity falls below the standards set forth in such compendium.
22 Such determination as to strength, quality or purity, shall be
23 made in accordance with the tests or methods of assay set forth
24 in such compendium, or in the absence of or inadequacy of such
25 tests or methods of assay those prescribed under the authority
26 of the Federal act. No drug OR DEVICE defined in an official <--
27 compendium shall be deemed to be adulterated under this
28 subsection because it differs from the standard of strength,
29 quality or purity therefor set forth in such compendium, if its
30 difference in strength, quality or purity from such standard is
19710H0851B2553 - 38 -
1 plainly stated on its label. Whenever a drug is recognized in <--
2 both the United States Pharmacopoeia and the Homeopathic
3 Pharmacopoeia of the United States, it shall be subject to the
4 requirements of the United States Pharmacopoeia unless it is
5 labeled and offered for sale as a homeopathic drug, in which
6 case, it shall be subject to the provisions of the Homeopathic
7 Pharmacopoeia of the United States and not to those of the
8 United States Pharmacopoeia.
9 (3) If it is a color additive and is to be used or is
10 recommended for use as a hair dye and it is not exempt under
11 section 9 unless its label bears the following legend
12 conspicuously displayed thereon: "Caution. This product contains
13 ingredients which may cause skin irritation on certain
14 individuals and a preliminary test according to accompanying
15 directions should first be made. This product must not be used
16 for dyeing the eyelashes or eyebrows, to do so may cause
17 blindness," and the labeling bears adequate directions for such
18 preliminary testing. For the purpose of this paragraph, the term
19 "hair dye" shall not include eyelash dyes or eyebrow dyes.
20 (4) If it is not subject to the provisions of clause (2) of
21 this section and its strength differs from or its purity or
22 quality falls below that which it purports or is represented to
23 possess.
24 (5) If it is a drug OR DEVICE and any substance has been (i) <--
25 mixed or packed therewith so as to reduce its quality or
26 strength, or (ii) substituted wholly or in part therefor.
27 Section 8. Misbranding.--A CONTROLLED SUBSTANCE, OTHER drug <--
28 or device or cosmetic shall be deemed to be misbranded:
29 (1) If its labeling is false or misleading in any
30 particular.
19710H0851B2553 - 39 -
1 (2) If in package form unless it bears a label containing
2 (i) the name and place of business of the manufacturer, packer
3 or distributor, and (ii) an accurate statement of the quantity
4 of the contents in terms of weight measure or numerical count:
5 Provided, That under subclause (ii) of this clause, reasonable
6 variations shall be permitted and exemptions as to small
7 packages shall be established by regulations.
8 (3) If any word, statement or other information required by
9 or under authority of this act to appear on the label, or
10 labeling is not prominently placed thereon with such
11 conspicuousness (as compared with other words, statements,
12 designs or devices in the labeling), and in such terms as to
13 render it likely to be read and understood by the ordinary
14 individual under customary conditions of purchase and use.
15 (4) If it is for use by man and is a narcotic, depressant or <--
16 stimulant drug CONTROLLED SUBSTANCE designated BY FEDERAL LAW as <--
17 habit-forming, unless its label bears the name and quantity or <--
18 proportion of such substance or derivative and if required by
19 applicable Federal law or regulations, in juxtaposition
20 therewith the statement "Warning. May Be Habit-Forming."
21 (5) If it is a drug and is not designated solely by a name
22 recognized in an official compendium, unless its label bears (i)
23 the common or usual name of the drug, if such there be, and (ii)
24 in case it is fabricated from two or more ingredients, the
25 common or usual name of each active ingredient including the
26 kind and quantity or proportion of any alcohol and also
27 including whether active or not, the name and quantity or
28 proportion of any bromides, ether, chloroform, acetanilid,
29 acetphenetidin, amidopyrine, antipyrine, atropine, hyoscine,
30 hyoscyamine, arsenic, digitalis glucosides GLYCOSIDES, mercury, <--
19710H0851B2553 - 40 -
1 ouabain, strophanthin, strychnine, thyroid or any derivative or
2 preparation of any such substances contained therein: Provided,
3 That to the extent that compliance with the requirements of
4 subclause (ii) of this clause is impracticable, exemptions shall
5 be established by regulations.
6 (6) Unless its labeling bears (i) adequate directions for
7 use, and (ii) such adequate warnings against use in those
8 pathological conditions or by children where its use may be
9 dangerous to health or against unsafe dosage or methods or
10 duration of administration or application in such manner and
11 form as are necessary for the protection of users: Provided,
12 That where any requirement of subclause (i) of this clause as
13 applied to any drug, or device OR COSMETIC is not necessary for <--
14 the protection of the public health, regulations shall be
15 promulgated exempting such drug, or device or cosmetic from such <--
16 requirements.
17 (7) If it purports to be a drug OR DEVICE the name of which <--
18 is recognized in an official compendium, unless it is packaged
19 and labeled as prescribed therein: Provided, That the method of
20 packing PACKAGING may be modified with a consent of the <--
21 secretary. Whenever a drug is recognized in both the United <--
22 States Pharmacopoeia and the Homeopathic Pharmacopoeia of the
23 United States, it shall be subject to the requirements of the
24 United States Pharmacopoeia with respect to packaging and
25 labeling, unless it is labeled and offered for sale as a
26 homeopathic drug, in which case, it shall be subject to the
27 provisions of the Homeopathic Pharmacopoeia of the United States
28 and not to those of the United States Pharmacopoeia.
29 (8) If it has been found by the secretary to be a drug,
30 DEVICE OR COSMETIC liable to deterioration unless it is packaged <--
19710H0851B2553 - 41 -
1 in such form and manner and its label bears a statement
2 specifying such precautions against deterioration as the
3 secretary shall by regulation require as necessary for the
4 protection of public health. No such regulation shall be <--
5 established for any drug recognized in an official compendium,
6 or for any drug which regulations specifying precautions against
7 deterioration have been promulgated by the Secretary of Health,
8 Education and Welfare under the Federal act.
9 (9) If it is offered for sale or sold under the name of
10 another drug, device or cosmetic or brand of drug, device or
11 cosmetic, or if it is manufactured, packaged, labeled or sold in
12 such manner as to give rise to a reasonable probability that the
13 purchaser will be led to believe he is purchasing such drug,
14 device or cosmetic as another drug, device or cosmetic or as the
15 product of another manufacturer.
16 (10) If it is dangerous to health when used in the dosage or
17 with the frequency or duration prescribed, recommended or
18 suggested in the labeling thereof.
19 (11) A drug dispensed by filling or refilling a written or <--
20 oral prescription issued by a person licensed by law to
21 administer or prescribe such drug (except a drug sold in the
22 course of the conduct of a business of selling drugs pursuant to
23 diagnosis by mail) shall be exempt from the requirements of this
24 section, except clauses (1) and (9) if such drug bears a label
25 containing the name and place of business of the dispenser, the
26 serial number and date of such prescription, the name of the
27 person prescribing such drug, the name of the patient and such
28 directions for use and cautionary statements, if any, contained
29 in such prescription.
30 (12) (11) If it is a DRUG, DEVICE OR cosmetic and its <--
19710H0851B2553 - 42 -
1 container is so made, formed or filled as to be misleading.
2 (12) IF IT IS A CONTROLLED SUBSTANCE ITS COMMERCIAL <--
3 CONTAINER MUST BEAR A LABEL CONTAINING AN IDENTIFYING SYMBOL FOR
4 SUCH SUBSTANCE IN ACCORDANCE WITH FEDERAL REGULATIONS.
5 Section 9. Color Additives.--A color additive shall be
6 deemed unsafe unless there is in effect with respect to such
7 additive a regulation issued pursuant to the Federal act
8 permitting such use and unless such additive and use thereof
9 conforms in all respects to the requirements of the Federal act
10 and regulations issued pursuant thereto.
11 Section 10. New Drugs.--(a) No person shall sell, deliver, <--
12 offer for sale, hold for sale, or give away, any new drug unless
13 (i) an application with respect thereto has been approved OR A <--
14 NOTICE OF CLAIMED INVESTIGATIONAL EXEMPTION FOR A NEW DRUG HAS
15 BEEN FILED under the appropriate Federal act. or (ii) when not <--
16 subject to the Federal act unless such drug has been tested and
17 has not been found to be unsafe or ineffective for use under the
18 conditions prescribed, recommended or suggested in the labeling
19 thereof, and prior to selling or offering for sale such drug,
20 there has been filed with the secretary an application, setting
21 forth full reports of investigations which have been made to
22 show whether or not such drug is safe and effective for use, a
23 full list of the articles used as components of such drug, a
24 full statement of the composition of such drug, a full
25 description of the methods used in and the facilities and
26 controls used for the manufacture, processing and packing of
27 such drug, such samples of such drug and of the articles used as
28 components thereof as the secretary may require, and specimens
29 of the labeling proposed to be used for such drug.
30 (b) An application provided for in subsection (a) (ii) shall
19710H0851B2553 - 43 -
1 be submitted to the board for its recommendations but such
2 application shall become effective on the sixtieth day after the
3 filing thereof except that if the secretary finds, after due
4 notice to the applicant and giving him an opportunity for a
5 hearing, that the drug is not safe and effective for use under
6 the conditions prescribed, recommended or suggested in the
7 proposed labeling thereof, he shall prior to the effective date
8 of the application issue an order refusing to permit the
9 application to become effective.
10 (c) This section shall not apply:
11 (1) To a drug intended solely for investigational use by
12 experts qualified by scientific training and experience to
13 investigate the safety in drugs, provided the drug is plainly
14 labeled "For investigational use only," or words of similar
15 import, and provided such investigator furnishes a statement to
16 the secretary showing that he has adequate facilities for such
17 investigation;
18 (2) To a drug sold in this State at any time prior to
19 enactment of this act or introduced into interstate commerce at
20 any time prior to the enactment of the Federal act; or
21 (3) To any drug which is licensed under the animal virus
22 serum and toxin law of March 4, 1913 (21 U.S.C. 151, et seq.) or
23 under the Public Health Service Act of July 1, 1944 (42 U.S.C.
24 201, et seq.).
25 (d) An order refusing to permit an application under this
26 section to become effective may be revoked by the secretary.
27 Section 11. Professional Prescription, Administration, and
28 Dispensing.--(a) Except when dispensed directly by a licensed <--
29 (A) EXCEPT WHEN DISPENSED OR ADMINISTERED DIRECTLY TO THE <--
30 PATIENT BY A practitioner OR HIS AUTHORIZED AGENT, other than a <--
19710H0851B2553 - 44 -
1 pharmacist, to an ultimate user, no controlled substance in
2 Schedule II, may be dispensed without the written prescription
3 of a licensed practitioner, except in emergency situations, as <--
4 prescribed by the secretary by regulation. No prescription for a
5 controlled dangerous substance in Schedule II may be refilled. <--
6 (b) Except when dispensed directly by a licensed <--
7 practitioner, other than a pharmacist, to an ultimate user, no
8 controlled substance in Schedule III or IV, which is a <--
9 prescription drug as determined under the Federal Food, Drug and
10 Cosmetic Act, may be dispensed without a written or oral
11 prescription. Such prescriptions may SHALL not be filled or <--
12 refilled more than six months after the date thereof or be
13 refilled more than five times after the date of the prescription
14 unless renewed by the licensed practitioner. <--
15 (c) No controlled substance in Schedule V which is a drug <--
16 may be distributed or dispensed FOR other than for a medical <--
17 MEDICINAL purpose. <--
18 (d) A licensed practitioner may prescribe, administer, or <--
19 dispense a controlled dangerous substance or OTHER drug OR <--
20 DEVICE only (i) in good faith in the course of his professional
21 practice, (ii) within the scope of the patient relationship, and
22 (iii) in accordance with treatment principles accepted by a
23 responsible segment of the medical profession. A licensed <--
24 practitioner may cause a controlled dangerous substance, OTHER <--
25 DRUG OR DEVICE or drug to be administered by a professional
26 assistant under his direction and supervision.
27 (e) A veterinarian may prescribe, administer, or dispense a
28 controlled dangerous substance, or OTHER drug OR DEVICE only (i) <--
29 in good faith in the course of his professional practice, and
30 (ii) not for use by a human being. He may cause a controlled
19710H0851B2553 - 45 -
1 dangerous substance, or OTHER drug OR DEVICE to be administered <--
2 by a professional assistant under his direction and supervision.
3 (f) Any narcotic drug OR DEVICE dispensed by a pharmacist <--
4 pursuant to a written prescription shall bear ORDER WHICH BEARS <--
5 SHALL BEAR a label showing (i) the name and address of the
6 pharmacy and any registration number obtained pursuant to any
7 applicable Federal laws, (ii) the name of the patient, or, if
8 the patient is an animal, the name of the owner of the animal
9 and the species of the animal, (iii) the name, address, and any <--
10 registration number required to be obtained pursuant to any
11 applicable Federal laws, of the practitioner by whom the
12 prescription ORDER was written, and (iv) such directions as may <--
13 be stated on the prescription ORDER INCLUDING THE STATEMENT <--
14 "TRANSFER OF THIS DRUG TO ANYONE OTHER THAN THE PATIENT FOR WHOM
15 IT WAS PRESCRIBED IS ILLEGAL" AND (V) THE SERIAL NUMBER AND DATE
16 OF FILING OF THE PRESCRIPTION ORDER. AND (IV) THE SERIAL NUMBER
17 AND DATE OF FILING OF THE PRESCRIPTION ORDER. IN ADDITION, THE
18 FOLLOWING STATEMENT SHALL BE REQUIRED ON THE LABEL OF A
19 CONTROLLED SUBSTANCE: "TRANSFER OF THIS DRUG TO ANYONE OTHER
20 THAN THE PATIENT FOR WHOM IT WAS PRESCRIBED IS ILLEGAL."
21 Section 12. Records of Distribution of Controlled Dangerous <--
22 Substances. and Drugs,--(a) Every person who sells or otherwise <--
23 distributes controlled dangerous substances, or controlled <--
24 drugs, shall keep records of all purchases or other receipt and
25 sales or other distribution of such drugs SUBSTANCES for two <--
26 years from the date of purchase or sale. Such records shall
27 include the name and address of the person from whom purchased
28 or otherwise received or to whom sold or otherwise distributed,
29 the date of purchase or receipt or sale or distribution, and the
30 quantity involved: Provided, however, That this subsection shall
19710H0851B2553 - 46 -
1 not apply to a licensed practitioner authorized by law to <--
2 administer and dispense who dispenses controlled dangerous <--
3 substances or drugs SUBSTANCES to his patients, unless the <--
4 licensed practitioner is regularly engaged in charging his <--
5 patients, whether separately or together with charges for other
6 professional services, for substances so dispensed.
7 (b) Every practitioner licensed by law to administer,
8 dispense or distribute narcotic drugs CONTROLLED SUBSTANCES <--
9 shall keep a record of all such substances and drugs, <--
10 administered, dispensed or distributed by him, showing the
11 amount administered, dispensed or distributed, the date, the
12 name and address of the patient, and in the case of a
13 veterinarian, the name and address of the owners of the animal
14 to whom such drugs SUBSTANCES are dispensed or distributed. Such <--
15 record shall be kept for two years from the date of
16 administering, dispensing or distributing such drug SUBSTANCE <--
17 and shall be open for inspection by the proper authorities.
18 (C) PERSONS REGISTERED OR LICENSED TO MANUFACTURE OR <--
19 DISTRIBUTE OR DISPENSE A CONTROLLED SUBSTANCE, OTHER DRUG OR
20 DEVICE UNDER THIS ACT SHALL KEEP RECORDS AND MAINTAIN
21 INVENTORIES IN CONFORMITY WITH THE RECORD-KEEPING, ORDER FORM <--
22 AND INVENTORY REQUIREMENTS OF FEDERAL LAW AND WITH ANY
23 ADDITIONAL REGULATIONS THE SECRETARY ISSUES. CONTROLLED <--
24 SUBSTANCES IN SCHEDULES I AND II SHALL BE DISTRIBUTED BY A
25 REGISTRANT TO ANOTHER REGISTRANT ONLY PURSUANT TO AN ORDER FORM.
26 Section 13. Lawful Acts.--The following acts are lawful <--
27 within the Commonwealth:
28 (1) The possession, control, dealing in, dispensing,
29 selling, delivery, distribution, prescription, trafficking in,
30 or giving of, any controlled dangerous substance, controlled
19710H0851B2553 - 47 -
1 paraphernalia or controlled drug in strict compliance with the
2 provisions of this act and in the regular and lawful course of a
3 business, profession, employment, occupation or duties of (i)
4 manufacturers of drugs, (ii) persons engaged in the wholesale
5 drug trade, (iii) importers or exporters of drugs, (iv)
6 registered pharmacists in any licensed pharmacy, (v) bona fide
7 owners of pharmacies or drugstores, (vi) practitioners licensed
8 by law to administer, prescribe or dispense such drugs, (vii)
9 persons in the employ of the United States or of this
10 Commonwealth or of any county, municipality or township of this
11 Commonwealth and having such drugs in their possession by reason
12 of their official duties, (viii) warehousemen or common carriers
13 engaged bona fide in handling or transporting drugs, (ix) nurses
14 under the supervision of a physician, (x) persons in charge of a
15 laboratory where such drugs are used for the purpose of medical
16 or scientific investigation, teaching or analysis and not for
17 further distribution, (xi) captains or proper officers of ships,
18 upon which no regular physician is employed, for the actual
19 medical needs of the officers and crew of their own ships only,
20 (xii) persons in the bona fide employ of any of the persons
21 above enumerated, (xiii) the provisions of this clause
22 pertaining to possession shall also apply to, in addition to the
23 foregoing, (A) persons having said drugs in their possession for
24 their own personal use only: Provided, That they have obtained
25 the same in good faith, for their own use, from a practitioner
26 licensed to prescribe or dispense such drugs, or in pursuance of
27 a prescription given them by a practitioner licensed to
28 prescribe such drugs or except as otherwise authorized by this
29 act, (B) persons having said drugs in their possession for the
30 use of an animal belonging to them: Provided, That they have
19710H0851B2553 - 48 -
1 obtained the same in good faith, from a duly licensed
2 veterinarian, for the use of such animal, or in pursuance of a
3 prescription given by a duly licensed veterinarian.
4 (2) The sale, dispensation, distribution or gift by any
5 manufacturer, producer, importer or person engaged in the
6 wholesale drug trade of any controlled dangerous substance or
7 controlled drug as evidenced by a written order signed by the
8 person authorized by law to possess, sell, dispense or prescribe
9 such drugs to whom such drug is sold, dispensed, distributed or
10 given. "Written order" hereunder shall include bills of lading,
11 invoices, receipts or written memorandums signed by the person
12 authorized by law to receive such drugs, showing the names and
13 quantities of drugs purchased.
14 (3) The sale, dispensation, distribution or gift by any
15 registered pharmacist in any licensed pharmacy of any controlled
16 dangerous substance or controlled drug to (i) a practitioner
17 licensed by law to administer, dispense or prescribe such drug,
18 (ii) a bona fide hospital, dispensary, asylum, sanatorium or
19 public institution, (iii) an individual in pursuance of a
20 written prescription, or an oral prescription subject to the
21 requirements hereinafter set forth, issued by a practitioner
22 licensed by law to prescribe such drug, which prescription shall
23 be dated as of the day on which signed and shall be signed by
24 the practitioner who issued the same, (iv) a person in charge of
25 a laboratory where such drugs are used in medical or scientific
26 investigation, teaching or analysis and not for sale or further
27 distribution, (v) the captain or proper officer of a ship upon
28 which no regular physician is employed for the actual medical
29 needs of the officers and crew of such ship only, (vi) a person
30 in the employ of the United States or of this Commonwealth or of
19710H0851B2553 - 49 -
1 any county, municipality or township thereof, purchasing or
2 receiving the same in his official capacity.
3 (4) Using, taking, administering to the person or causing to
4 be administered to the person, or administering to any other
5 person or causing to be administered to any other person, any
6 controlled dangerous substance or controlled drug under the
7 advice and direction and with the consent of a practitioner
8 licensed by law to prescribe or administer such drugs to human
9 beings.
10 Section 14. Prohibited Acts; Penalties.--(a) The following
11 commercial type acts and the causing thereof within the
12 Commonwealth are hereby prohibited:
13 (1) The manufacture, sale or delivery, holding, offering for
14 sale, or possession of any drug, device or cosmetic that is
15 adulterated or misbranded.
16 (2) The adulteration or misbranding of any drug, device or
17 cosmetic.
18 (3) The receipt in commerce of any drug, device or cosmetic
19 that is adulterated or misbranded and the delivery or proffered
20 delivery thereof for pay or otherwise.
21 (4) The sale, delivery for sale, holding for sale or
22 offering for sale of any article in violation of section 10.
23 (5) The dissemination or publication of any false or
24 materially misleading advertisement.
25 (6) The removal or disposal of a detained or embargoed
26 article in violation of section 25, whether or not such article
27 is in fact adulterated or misbranded.
28 (7) The adulteration, mutilation, destruction, obliteration
29 or removal of the whole or any part of the labeling of, or the
30 doing of any other act with respect to a drug, device or
19710H0851B2553 - 50 -
1 cosmetic, if such act is done while such article is held for
2 sale and results in such article being adulterated or
3 misbranded.
4 (8) Forging, counterfeiting, simulating or falsely
5 representing, or without proper authority using any mark, stamp,
6 tag, label or other identification device authorized or required
7 by regulation promulgated under the provisions of this act.
8 (9) Placing or causing to be placed upon any drug or
9 pharmaceutical preparation, or upon the container of any drug or
10 pharmaceutical preparation, with intent to defraud, the
11 trademark, trade name or other identifying mark, imprint or
12 device of another, or any likeness of any of the foregoing.
13 (10) Selling, dispensing, disposing of or causing to be
14 sold, dispensed or disposed of, or keeping in possession,
15 control or custody, or concealing any drug or pharmaceutical
16 preparation or any container of any drug or pharmaceutical
17 preparation with knowledge that the trademark, trade name or
18 other identifying mark, imprint or device of another, or any
19 likeness of any of the foregoing, has been placed thereon in a
20 manner prohibited by clause (9) hereof.
21 (11) Making, selling, disposing of or causing to be made,
22 sold, or disposed of, or keeping in possession, control or
23 custody, or concealing with intent to defraud, any punch, die,
24 plate, stone or other thing designed to print, imprint or
25 reproduce the trademark, trade name or other identifying mark,
26 imprint or device of another or any likeness of any of the
27 foregoing upon any drug, pharmaceutical preparation, or
28 container thereof.
29 (12) The use on the labeling of any drug, or in any
30 advertisement relating to such drug, of any representation or
19710H0851B2553 - 51 -
1 suggestion that any application with respect to such drug is
2 effective under section 10 or that such drug complies with the
3 provisions of such section.
4 (13) The use of any statement or representation in
5 advertising or promoting the retail sale of any drug that the
6 seller of such drug is registered under this act.
7 (14) The sale at retail of a nonproprietary drug except by a
8 registered pharmacist in a licensed pharmacy or by a
9 practitioner.
10 (15) The operation of a drug manufacturing, wholesaling or
11 retailing establishment, except by registered pharmacists in a
12 licensed pharmacy, without conforming with such standards
13 respecting sanitation, materials, equipment and supplies as the
14 secretary, after consultation with the board, may establish by
15 regulation for the protection of the public health and safety.
16 (16) The sale, dispensation, distribution or gift by any
17 registered pharmacist or operator of a licensed pharmacy of any
18 controlled dangerous substance or controlled drug listed in
19 Schedules II, III and IV of section 4 except in pursuance of an
20 oral order or a written order signed by the person to whom such
21 drugs are sold, dispensed, distributed or given as provided for
22 in section 11, when such drugs are sold, dispensed, distributed
23 or given to an individual in pursuance of a prescription. Such
24 prescription shall be regarded as the written order herein
25 required and no further written order shall be necessary. Such
26 orders shall be kept and preserved for a period of two years.
27 Where there is no initial written order in an emergency
28 situation, said order shall be verified by a written memorandum
29 signed by the vendee.
30 (17) The sale, dispensation, distribution, prescription or
19710H0851B2553 - 52 -
1 gift by any practitioner otherwise authorized by law so to do of
2 any controlled drug or controlled dangerous substance to any
3 person known to such practitioner to be a drug dependent person,
4 unless said drug is prescribed, administered, dispensed or
5 given, for the cure or treatment of some malady other than the
6 drug habit, except that a controlled drug such as methadone may
7 be permitted by such regulations for the treatment of the drug
8 habit pursuant to regulations providing for such use.
9 (18) The administration, dispensation, delivery, gift or
10 prescription by any practitioner otherwise authorized by law so
11 to do of any controlled dangerous substance or controlled drug
12 except after a physical or visual examination of the person or
13 animal for whom said drugs are intended, said examination to be
14 made at the time said prescription is issued or at the time said
15 drug is administered, dispensed, given away or delivered by said
16 practitioner, or except where the practitioner is satisfied by
17 evidence that the person is not a drug dependent person. No
18 veterinarian shall sell, dispense, distribute, give or prescribe
19 any narcotic drug for the use of a human being.
20 (19) The sale at retail or dispensing of any controlled drug
21 or controlled dangerous substance listed in Schedules II, III
22 and IV to any person, except to one authorized by law to sell,
23 dispense, prescribe or possess such drugs or substances, unless
24 upon the written or oral prescription of a person licensed by
25 law to prescribe such drug and unless compounded or dispensed by
26 a registered pharmacist or under the immediate personal
27 supervision of a registered pharmacist, or the refilling of a
28 written or oral prescription for a drug, unless such refilling
29 is authorized by the prescriber either in the original written
30 prescription or by written confirmation of the original oral
19710H0851B2553 - 53 -
1 prescription. The provisions of this subsection shall not apply
2 to a practitioner licensed to prescribe or dispense such drugs,
3 who keeps a record of the amount of such drugs purchased and a
4 dispensing record showing the date, name, and quantity of the
5 drug dispensed and the name and address of the patient, as
6 required by this act.
7 (20) The dispensing of any controlled drug or controlled
8 dangerous substance by a pharmacist without affixing to the
9 container in which the drug is sold or dispensed a label bearing
10 the name and address of the pharmacy, the name of the patient,
11 the date compounded and the consecutive number of the
12 prescription under which it is recorded in his prescription
13 files, together with the name of the practitioner prescribing
14 it.
15 (21) The dispensing of a controlled drug or controlled
16 dangerous substance by a practitioner otherwise authorized by
17 law so to do without affixing to the container in which the drug
18 is sold or dispensed a label bearing the name and address of the
19 practitioner, the date dispensed, the name of the patient and
20 the directions for the use of the drug by the patient.
21 (22) The selling or possession by a pharmacy or wholesaler
22 of any drug or controlled dangerous substance defined herein
23 unless the container bears a label, securely attached thereto,
24 stating conspicuously the specific name of the drug and the
25 proportion or amount thereof. Such label shall not be necessary
26 when the drug is dispensed by a pharmacist upon a prescription
27 or dispensed by a practitioner authorized by law to dispense
28 such drugs to his own patients and the container is labeled in
29 the manner prescribed in this act.
30 (23) The purchase or receipt in commerce by any person of
19710H0851B2553 - 54 -
1 any drugs or devices from any person not authorized by law to
2 sell, distribute, dispense or otherwise deal in such drugs or
3 devices.
4 (24) The using by any person to his own advantage or
5 revealing other than to the secretary or officers or employes of
6 the Department of Health or to the council or to the board or to
7 courts or a hearing examiner when relevant to proceedings under
8 this act any information acquired under authority of this act
9 concerning any method or process which as a trade secret is
10 entitled to protection. Such information obtained under the
11 authority of this act shall not be admitted in evidence in any
12 proceeding before any court of the Commonwealth except in
13 proceedings under this act.
14 Any person who violates any of the provisions of this
15 subsection (a) shall be guilty of a misdemeanor, and shall, on
16 conviction thereof, be sentenced to imprisonment for not more
17 than one year or a fine of not more than five thousand dollars
18 ($5,000), or both; but if the violation is committed after a
19 prior conviction of such person, for a violation of this act
20 under this section, has become final, such person shall be
21 sentenced to imprisonment for not more than three years or a
22 fine of not more than twenty-five thousand dollars ($25,000), or
23 both.
24 (b) Any person who is an otherwise legitimate producer,
25 manufacturer, or distributor and who fails to register or obtain
26 a license as required by this act shall be guilty of a
27 misdemeanor, and shall, on conviction thereof, be punished only
28 as follows:
29 (1) Upon conviction of the first such offense, he shall be
30 sentenced to imprisonment for not more than six months, or fined
19710H0851B2553 - 55 -
1 not exceeding ten thousand dollars ($10,000), or both.
2 (2) Upon conviction of the second and subsequent such
3 offense, he shall be sentenced to imprisonment for not more than
4 two years, or fined not exceeding forty thousand dollars
5 ($40,000), or both.
6 (c) Any person who fails to maintain or permit inspection of
7 records as required by this act or divulges information in
8 violation of this act shall be guilty of a felony, and shall, on
9 conviction thereof, be punished as follows:
10 (1) Upon conviction of the first such offense, he shall be
11 sentenced to imprisonment for not more than two years, or fined
12 not exceeding ten thousand dollars ($10,000), or have his
13 license revoked for not exceeding one year, or any of these.
14 (2) Upon conviction of the second and subsequent such
15 offense, he shall be sentenced to imprisonment for not more than
16 ten years, or fined not exceeding thirty thousand dollars
17 ($30,000), or have his license revoked for not more than five
18 years, or any of these.
19 (d) Any person, not authorized by law to do so, who
20 acquires, receives, possesses, stores, sells or distributes any
21 controlled paraphernalia shall be guilty of a felony and shall,
22 on conviction thereof, be sentenced to imprisonment for not more
23 than three years or a fine of not more than five thousand
24 dollars ($5,000), or both.
25 (e) It shall be unlawful for any person to obtain or attempt
26 to obtain a controlled dangerous substance or controlled drug
27 by:
28 (1) Misrepresentation, deception, or subterfuge, (i) from
29 any person that he believes uses such a substance or drug in
30 research, teaching, or chemical analysis, and who in fact is
19710H0851B2553 - 56 -
1 authorized by law to administer, dispense, or distribute such a
2 substance or drug; or (ii) from any person that he believes is
3 lawfully entitled to possess and distribute a controlled
4 dangerous substance or controlled drug, and who in fact is
5 authorized by law to administer, dispense, or distribute such a
6 substance or drug;
7 (2) Use of a prescription that has been forged, or that has
8 been altered by someone other than the prescribing practitioner;
9 or
10 (3) Use of a false name or address on a prescription.
11 Any person who obtained a controlled drug or controlled
12 dangerous substance by any means of fraud or deceit as herein
13 set forth shall be guilty of a misdemeanor and shall, upon
14 conviction thereof, be punished as follows:
15 (1) Upon conviction of the first such offense, he shall be
16 sentenced to imprisonment for not more than one year, or fined
17 not exceeding five thousand dollars ($5,000), or both.
18 (2) Upon conviction of the second and subsequent such
19 offense, he shall be sentenced to imprisonment for not more than
20 two years, or fined not exceeding ten thousand dollars
21 ($10,000), or both.
22 (3) Any person who is a drug dependent person and who
23 violates this provision to satisfy his drug dependence, and who
24 is not charged with a trafficking offense involving distribution
25 of a controlled drug or controlled dangerous substance at
26 wholesale or distribution at retail of any controlled drug or
27 dangerous substance as part of an organized professional system,
28 shall be handled only pursuant to the provisions relating to
29 care, treatment and civil commitment.
30 (f) It shall be unlawful for any person who is not
19710H0851B2553 - 57 -
1 registered or licensed as required by law to possess a
2 controlled drug or controlled dangerous substance with intent to
3 distribute it or to distribute a controlled drug or controlled
4 dangerous substance in violation of this act and shall, upon
5 conviction thereof, be punished as follows:
6 (1) Trafficking in the First Degree. A person who in
7 violation of this act possesses a controlled drug or controlled
8 dangerous substance except marihuana with intent to distribute
9 it or who in violation of this act distributes a controlled drug
10 or controlled dangerous substance except marihuana at wholesale
11 to another distributor shall be guilty of a felony, and shall,
12 on conviction thereof, be punished as follows:
13 (i) upon conviction of the first such offense involving a
14 controlled drug or controlled dangerous substance classified in
15 Schedule I or II which is a narcotic drug, such person shall be
16 sentenced to imprisonment for not more than twenty years and
17 fined without limitation an amount sufficient to exhaust the
18 assets utilized in and the profits obtained by the illegal
19 activity and upon conviction of the second and subsequent such
20 offense, he shall be sentenced to imprisonment for not more than
21 life, and fined without limitation an amount sufficient to
22 exhaust the assets utilized in and the profits obtained by the
23 illegal activity;
24 (ii) upon conviction of the first such offense involving a
25 controlled drug or dangerous substance classified in Schedule I
26 or II which is not a narcotic drug or any controlled drug or
27 controlled dangerous substance classified in Schedule III, such
28 person shall be sentenced to imprisonment for not more than five
29 years, or fined not exceeding fifteen thousand dollars
30 ($15,000), or both and upon conviction of the second and
19710H0851B2553 - 58 -
1 subsequent such offense, he shall be sentenced to imprisonment
2 for not more than ten years, or fined not exceeding thirty
3 thousand dollars ($30,000), or both;
4 (iii) upon conviction of the first such offense involving a
5 controlled drug or controlled dangerous substance classified in
6 Schedule IV, such person shall be sentenced to imprisonment for
7 not more than three years, or fined not exceeding ten thousand
8 dollars ($10,000), or both and upon conviction of the second and
9 subsequent such offense, he shall be sentenced to imprisonment
10 of not more than six years, or fined not exceeding twenty
11 thousand dollars ($20,000), or both;
12 (iv) upon conviction of the first such offense involving a
13 controlled drug or controlled dangerous substance classified in
14 Schedule V, such person shall be sentenced to imprisonment of
15 not more than one year, or fined not exceeding five thousand
16 dollars ($5,000), or both and upon conviction of the second and
17 subsequent such offense, he shall be sentenced to imprisonment
18 for not more than two years, or fined not exceeding ten thousand
19 dollars ($10,000), or both.
20 (2) Trafficking in the Second Degree. A person who in
21 violation of this act possesses a controlled drug or controlled
22 dangerous substance except marihuana with intent to distribute
23 it to an ultimate user thereof in violation of this act, or who
24 in violation of this act distributes a controlled drug or
25 controlled dangerous substance except marihuana to an ultimate
26 user thereof, shall be guilty of a felony, and shall, on
27 conviction thereof, be punished as follows:
28 (i) upon conviction of the first such offense involving a
29 controlled drug or controlled dangerous substance classified in
30 Schedule I or II which is a narcotic drug, such person shall be
19710H0851B2553 - 59 -
1 sentenced to imprisonment for not more than twenty years, and
2 fined an amount sufficient to exhaust the assets utilized in and
3 the profits obtained by the illegal activity, and upon
4 conviction of the second and subsequent such offense, he shall
5 be sentenced to imprisonment for not more than forty years, and
6 fined an amount sufficient to exhaust the assets utilized in and
7 the profits obtained by the illegal activity;
8 (ii) upon conviction of the first such offense involving a
9 controlled drug or controlled dangerous substance classified in
10 Schedule I or II which is not a narcotic drug or any controlled
11 drug or controlled dangerous substance classified in Schedule
12 III, such person shall be sentenced to imprisonment for not more
13 than five years, or fined not exceeding five thousand dollars
14 ($5,000), or both and upon conviction of the second and
15 subsequent such offense, he shall be sentenced to imprisonment
16 for not more than ten years, or fined not exceeding ten thousand
17 dollars ($10,000), or both;
18 (iii) upon conviction of the first such offense involving a
19 controlled drug or controlled dangerous substance classified in
20 Schedule IV, such person shall be sentenced to imprisonment for
21 not more than three years, or fined not exceeding three thousand
22 dollars ($3,000), or both and upon conviction of the second and
23 subsequent such offense, he shall be sentenced to imprisonment
24 for not more than six years, or fined not exceeding six thousand
25 dollars ($6,000), or both;
26 (iv) upon conviction of the first such offense involving a
27 controlled drug or controlled dangerous substance classified in
28 Schedule V, such person shall be sentenced to imprisonment for
29 not more than one year, or fined not exceeding two thousand
30 dollars ($2,000), or both, and upon conviction of the second and
19710H0851B2553 - 60 -
1 subsequent such offense, he shall be sentenced to imprisonment
2 for not more than two years, or fined not exceeding three
3 thousand dollars ($3,000), or both.
4 (3) Trafficking in the Third Degree. A person who in
5 violation of this act possesses marihuana with intent to
6 distribute it, or who in violation of this act distributes
7 marihuana, shall be guilty of a felony, and shall, on conviction
8 thereof, be punished as follows:
9 (i) upon conviction of the first such offense, he shall be
10 sentenced to imprisonment for not more than ten years, and fined
11 an amount sufficient to exhaust the assets utilized in and the
12 profits obtained by the illegal activity;
13 (ii) upon conviction of the second such offense, he shall be
14 sentenced to imprisonment for not more than twenty years, and
15 fined an amount sufficient to exhaust the assets utilized in and
16 the profits obtained by the illegal activity.
17 (g) Any person who manufactures or distributes a counterfeit
18 drug or substance or who possesses a counterfeit drug or
19 substance with intent to distribute it, knowing it to be a
20 counterfeit drug or substance, or who manufactures or
21 distributes any device intended to reproduce any identifying
22 name or mark upon any drug or substance or container or labeling
23 so as to render such drug or substance a counterfeit drug, shall
24 be guilty of a felony, and shall, upon conviction thereof, be
25 punished as follows:
26 (1) Upon conviction of the first such offense involving a
27 counterfeit substance classified in Schedule I or II which is a
28 narcotic drug, such person shall be sentenced to imprisonment
29 for not more than ten years, and fined without limitation in an
30 amount sufficient to exhaust the assets utilized in and the
19710H0851B2553 - 61 -
1 profits obtained by the illegal activity and upon conviction of
2 the second and subsequent such offense, he shall be sentenced to
3 imprisonment for not more than thirty years, and fined without
4 limitation an amount sufficient to exhaust the assets utilized
5 in and the profits obtained by the illegal activity.
6 (2) Upon conviction of the first such offense involving a
7 counterfeit substance classified in Schedule I or II which is
8 not a narcotic drug or any counterfeit substance classified in
9 Schedule III, shall be sentenced to imprisonment for not more
10 than five years, or fined not exceeding ten thousand dollars
11 ($10,000), or both and upon the second and subsequent such
12 offense, he shall be sentenced to imprisonment for not more than
13 ten years, or fined not exceeding twenty thousand dollars
14 ($20,000), or both.
15 (3) Upon conviction of the first such offense involving a
16 counterfeit substance classified in Schedule IV, such person
17 shall be sentenced to imprisonment for not more than three
18 years, or fined not exceeding seven thousand five hundred
19 dollars ($7,500), or both and upon conviction of the second and
20 subsequent such offense, he shall be sentenced to imprisonment
21 for not more than six years, or fined not exceeding fifteen
22 thousand dollars ($15,000), or both.
23 (4) Upon conviction of the first such offense involving a
24 counterfeit substance classified in Schedule V, such person
25 shall be sentenced to imprisonment for not more than one year,
26 or fined not exceeding five thousand dollars ($5,000), or both
27 and upon conviction of the second and subsequent such offense,
28 he shall be sentenced to imprisonment for not more than two
29 years, or fined not exceeding ten thousand dollars ($10,000), or
30 both.
19710H0851B2553 - 62 -
1 (h) Any person who acquires a controlled drug or controlled
2 dangerous substance in violation of this act with intent to
3 distribute, administer, or dispense it in accordance with this
4 act, or who acquires a controlled drug or controlled dangerous
5 substance in violation of this act and distributes, administers,
6 or dispenses it in accordance with this act, shall be guilty of
7 a felony, and shall, on conviction thereof, be punished only as
8 follows:
9 (1) Upon conviction of the first such offense involving a
10 controlled drug or controlled dangerous substance classified in
11 Schedule I or II which is a narcotic drug, such person shall be
12 sentenced to imprisonment for not more than four years, or fined
13 not exceeding twenty thousand dollars ($20,000), or have his
14 license suspended for not exceeding six months, or any of these
15 and upon conviction of the second and subsequent such offense,
16 he shall be sentenced to imprisonment for not more than ten
17 years, or fined not exceeding fifty thousand dollars ($50,000),
18 or have his license suspended or revoked, or any of these.
19 (2) Upon conviction of the first such offense involving a
20 controlled drug or controlled dangerous substance classified in
21 Schedule I or II which is not a narcotic drug and any controlled
22 drug or controlled dangerous substance classified in Schedule
23 III, such person shall be sentenced to imprisonment for not more
24 than three years, or fined not exceeding fifteen thousand
25 dollars ($15,000), or have his license suspended for not
26 exceeding four months, or any of these and upon conviction of
27 the second and subsequent such offense, he shall be sentenced to
28 imprisonment for not more than eight years, or fined not
29 exceeding thirty thousand dollars ($30,000), or have his license
30 suspended or revoked, or any of these.
19710H0851B2553 - 63 -
1 (3) Upon conviction of the first such offense involving a
2 controlled drug or controlled dangerous substance classified in
3 Schedule IV, such person shall be sentenced to imprisonment for
4 not more than two years, or fined not exceeding ten thousand
5 dollars ($10,000), or have his license suspended for not
6 exceeding three months, or any of these and upon conviction of
7 the second and subsequent such offense, he shall be sentenced to
8 imprisonment for not more than six years, or fined not exceeding
9 twenty thousand dollars ($20,000), or have his license suspended
10 or revoked, or any of these.
11 (4) Upon conviction of the first such offense involving a
12 controlled drug or controlled dangerous substance classified in
13 Schedule V, such person shall be sentenced to imprisonment for
14 not more than one year, or fined not exceeding five thousand
15 dollars ($5,000), or have his license suspended for not
16 exceeding two months, or any of these and upon conviction of the
17 second and subsequent offense, he shall be sentenced to
18 imprisonment for not more than four years, or fined not
19 exceeding ten thousand dollars ($10,000), or have his license
20 suspended or revoked, or any of these.
21 (i) Any person who prescribes, administers, dispenses, or
22 investigates a controlled drug or controlled dangerous substance
23 in violation of this act shall be guilty of a misdemeanor for
24 the first and second offense and shall be guilty of a felony for
25 the third and subsequent offense and shall, on conviction
26 thereof, be punished as follows:
27 (1) Upon conviction of the first and second such offense
28 involving a controlled drug or controlled dangerous substance
29 classified in Schedule I or II which is a narcotic drug, such
30 person shall be sentenced to imprisonment for not more than one
19710H0851B2553 - 64 -
1 year, or fined not more than five thousand dollars ($5,000), or
2 have his license suspended for not exceeding three months, or
3 any of these and upon conviction of the third and subsequent
4 such offense he shall be sentenced to imprisonment for not more
5 than ten years, or fined not exceeding thirty thousand dollars
6 ($30,000), or have his license suspended or revoked, or any of
7 these.
8 (2) Upon conviction of the first and second such offense
9 involving a controlled drug or controlled dangerous substance
10 classified in Schedule I or II which is not a narcotic drug, and
11 any controlled drug or controlled dangerous substance classified
12 in Schedule III, such person shall be sentenced to imprisonment
13 for not more than six months, or fined not more than three
14 thousand dollars ($3,000), or have his license suspended for not
15 exceeding two months, or any of these and upon conviction of the
16 third and subsequent such offense he shall be sentenced to
17 imprisonment for not more than eight years, or fined not
18 exceeding eighteen thousand dollars ($18,000), or have his
19 license suspended or revoked, or any of these.
20 (3) Upon conviction of the first and second such offense
21 involving a controlled drug or controlled dangerous substance
22 classified in Schedule IV, such person shall be sentenced to
23 imprisonment for not more than three months, or fined not
24 exceeding two thousand dollars ($2,000), or have his license
25 suspended for not exceeding one month, or any of these and upon
26 conviction of the third and subsequent such offense he shall be
27 sentenced to imprisonment for not more than six years, or fined
28 not exceeding twelve thousand dollars ($12,000), or have his
29 license suspended or revoked, or any of these.
30 (4) Upon conviction of the first and second such offense
19710H0851B2553 - 65 -
1 involving a controlled drug or controlled dangerous substance
2 classified in Schedule V, such person shall be sentenced to
3 imprisonment for not more than two months, or fined not
4 exceeding one thousand dollars ($1,000), or have his license
5 suspended for not exceeding one month, or any of these and upon
6 conviction of the third and subsequent such offense he shall be
7 sentenced to imprisonment for not more than four years, or fined
8 not exceeding six thousand dollars ($6,000), or have his license
9 suspended or revoked, or any of these.
10 (j) Any person who has possession illegally of any
11 controlled drug or controlled dangerous substance for personal
12 use or distribution not for remuneration shall be guilty of a
13 misdemeanor, and shall, on conviction thereof, be punished only
14 as follows:
15 (1) Possession in the First Degree. Any person who in
16 violation of this act possesses a controlled drug or controlled
17 dangerous substance except marihuana for personal use, or who in
18 violation of this act possesses a controlled drug or controlled
19 dangerous substance except marihuana with intent to distribute
20 it but not for remuneration or for the purpose of making another
21 dependent upon the drug or substance, or who in violation of
22 this act distributes a controlled drug or controlled dangerous
23 substance except marihuana but not for remuneration or for the
24 purpose of making another dependent upon the drug or substance,
25 shall be admonished by the court about the seriousness of the
26 violation, or required to complete a course on drug abuse
27 prescribed by the council, or imprisoned not exceeding two
28 years, or fined not exceeding ten thousand dollars ($10,000), or
29 any of these.
30 (2) Possession in the Second Degree. Any person who in
19710H0851B2553 - 66 -
1 violation of this act possesses marihuana for personal use, or
2 who in violation of this act possesses marihuana with intent to
3 distribute it but not for remuneration or for the purpose of
4 introducing another to the drug, or who in violation of this act
5 distributes marihuana but not for remuneration or for the
6 purpose of introducing another to the drug shall be admonished
7 by the court about the seriousness of the violation, or required
8 to complete a prescribed course on drug abuse, or imprisonment
9 not exceeding thirty days, or fined not exceeding five hundred
10 dollars ($500), or any of these.
11 SECTION 13. PROHIBITED ACTS; PENALTIES.--(A) THE FOLLOWING <--
12 ACTS AND THE CAUSING THEREOF WITHIN THE COMMONWEALTH ARE HEREBY
13 PROHIBITED:
14 (1) THE MANUFACTURE, SALE OR DELIVERY, HOLDING, OFFERING FOR
15 SALE, OR POSSESSION OF ANY CONTROLLED SUBSTANCE, OTHER DRUG,
16 DEVICE OR COSMETIC THAT IS ADULTERATED OR MISBRANDED.
17 (2) THE ADULTERATION OR MISBRANDING OF ANY CONTROLLED
18 SUBSTANCE, OTHER DRUG, DEVICE OR COSMETIC.
19 (3) THE DISSEMINATION OR PUBLICATION OF ANY FALSE OR
20 MATERIALLY MISLEADING ADVERTISEMENT.
21 (4) THE REMOVAL OR DISPOSAL OF A DETAINED OR EMBARGOED
22 SUBSTANCE OR ARTICLE, WHETHER OR NOT SUCH SUBSTANCE OR ARTICLE
23 IS IN FACT ADULTERATED OR MISBRANDED.
24 (5) THE ADULTERATION, MUTILATION, DESTRUCTION, OBLITERATION
25 OR REMOVAL OF THE WHOLE OR ANY PART OF THE LABELING OF, OR THE
26 DOING OF ANY OTHER ACT WITH RESPECT TO A CONTROLLED SUBSTANCE,
27 OTHER DRUG, DEVICE OR COSMETIC, IF SUCH ACT IS DONE WHILE SUCH
28 SUBSTANCE OR ARTICLE IS HELD FOR SALE AND RESULTS IN SUCH
29 SUBSTANCE OR ARTICLE BEING ADULTERATED OR MISBRANDED.
30 (6) FORGING, COUNTERFEITING, SIMULATING OR FALSELY
19710H0851B2553 - 67 -
1 REPRESENTING, OR WITHOUT PROPER AUTHORITY USING ANY MARK, STAMP,
2 TAG, LABEL OR OTHER IDENTIFICATION SYMBOL AUTHORIZED OR REQUIRED
3 BY REGULATION PROMULGATED UNDER THE PROVISIONS OF THIS ACT.
4 (7) PLACING OR CAUSING TO BE PLACED UPON ANY CONTROLLED
5 SUBSTANCE, OTHER DRUG, DEVICE OR COSMETIC, OR UPON THE CONTAINER
6 OF ANY CONTROLLED SUBSTANCE, OTHER DRUG, DEVICE OR COSMETIC,
7 WITH INTENT TO DEFRAUD, THE TRADEMARK, TRADE NAME OR OTHER
8 IDENTIFYING MARK, IMPRINT OR SYMBOL OF ANOTHER, OR ANY LIKENESS
9 OF ANY OF THE FOREGOING.
10 (8) SELLING, DISPENSING, DISPOSING OF OR CAUSING TO BE SOLD,
11 DISPENSED OR DISPOSED OF, OR KEEPING IN POSSESSION, CONTROL OR
12 CUSTODY, OR CONCEALING ANY CONTROLLED SUBSTANCE, OTHER DRUG,
13 DEVICE OR COSMETIC OR ANY CONTAINER OF ANY DRUG, DEVICE OR
14 COSMETIC WITH KNOWLEDGE THAT THE TRADEMARK, TRADE NAME OR OTHER
15 IDENTIFYING MARK, IMPRINT OR SYMBOL OF ANOTHER, OR ANY LIKENESS
16 OF ANY OF THE FOREGOING, HAS BEEN PLACED THEREON IN A MANNER
17 PROHIBITED BY CLAUSE (7) HEREOF.
18 (9) MAKING, SELLING, DISPOSING OF OR CAUSING TO BE MADE,
19 SOLD, OR DISPOSED OF, OR KEEPING IN POSSESSION, CONTROL OR
20 CUSTODY, OR CONCEALING WITH INTENT TO DEFRAUD, ANY PUNCH, DIE,
21 PLATE, STONE OR OTHER THING DESIGNED TO PRINT, IMPRINT OR
22 REPRODUCE THE TRADEMARK, TRADE NAME OR OTHER IDENTIFYING MARK,
23 IMPRINT OR SYMBOL OF ANOTHER OR ANY LIKENESS OF ANY OF THE
24 FOREGOING UPON ANY CONTROLLED SUBSTANCE, OTHER DRUG, DEVICE OR
25 COSMETIC OR CONTAINER THEREOF.
26 (10) THE SALE AT RETAIL OF A NONPROPRIETARY DRUG EXCEPT BY A
27 REGISTERED PHARMACIST IN A LICENSED PHARMACY OR BY A
28 PRACTITIONER.
29 (11) THE OPERATION OF A DRUG MANUFACTURING, DISTRIBUTING OR
30 RETAILING ESTABLISHMENT, EXCEPT BY REGISTERED PHARMACISTS IN A
19710H0851B2553 - 68 -
1 LICENSED PHARMACY, WITHOUT CONFORMING WITH SUCH STANDARDS
2 RESPECTING SANITATION, PERSONNEL, MATERIALS, EQUIPMENT AND
3 SUPPLIES AS THE SECRETARY, AFTER CONSULTATION WITH THE BOARD,
4 MAY ESTABLISH BY REGULATION FOR THE PROTECTION OF THE PUBLIC
5 HEALTH AND SAFETY.
6 (12) THE ACQUISITION OR OBTAINING OF POSSESSION OF A
7 CONTROLLED SUBSTANCE BY MISREPRESENTATION, FRAUD, FORGERY,
8 DECEPTION OR SUBTERFUGE.
9 (13) THE SALE, DISPENSING, DISTRIBUTION, PRESCRIPTION OR
10 GIFT BY ANY PRACTITIONER OTHERWISE AUTHORIZED BY LAW SO TO DO OF
11 ANY CONTROLLED SUBSTANCE TO ANY PERSON KNOWN TO SUCH
12 PRACTITIONER TO BE OR WHOM SUCH PRACTITIONER HAS REASON TO KNOW
13 IS A DRUG DEPENDENT PERSON, UNLESS SAID DRUG IS PRESCRIBED,
14 ADMINISTERED, DISPENSED OR GIVEN, FOR THE CURE OR TREATMENT OF
15 SOME MALADY OTHER THAN DRUG DEPENDENCY, EXCEPT THAT A CONTROLLED
16 SUBSTANCE, INCLUDING BUT NOT LIMITED TO, METHADONE MAY BE
17 PERMITTED FOR THE TREATMENT OF DRUG DEPENDENCY PURSUANT TO
18 REGULATIONS OF THE SECRETARY PROVIDING FOR SUCH USE. THIS CLAUSE
19 SHALL NOT PROHIBIT ANY PRACTITIONER FROM PRESCRIBING,
20 DISTRIBUTING OR DISPENSING ANY CONTROLLED SUBSTANCE ON A SHORT
21 TERM BASIS PENDING CONFIRMED ADMISSION OF THE PATIENT TO A
22 HOSPITAL OR REHABILITATION CENTER.
23 (14) THE ADMINISTRATION, DISPENSING, DELIVERY, GIFT OR
24 PRESCRIPTION BY ANY PRACTITIONER OTHERWISE AUTHORIZED BY LAW SO
25 TO DO OF ANY CONTROLLED SUBSTANCE EXCEPT AFTER A PHYSICAL OR
26 VISUAL EXAMINATION OF THE PERSON OR ANIMAL FOR WHOM SAID DRUGS
27 ARE INTENDED, SAID EXAMINATION TO BE MADE AT THE TIME SAID
28 PRESCRIPTION ORDER IS ISSUED OR AT THE TIME SAID DRUG IS
29 ADMINISTERED, DISPENSED, GIVEN AWAY OR DELIVERED BY SAID
30 PRACTITIONER, OR EXCEPT WHERE THE PRACTITIONER IS SATISFIED BY
19710H0851B2553 - 69 -
1 EVIDENCE THAT THE PERSON IS NOT A DRUG DEPENDENT PERSON.
2 (15) THE SALE AT RETAIL OR DISPENSING OF ANY CONTROLLED
3 SUBSTANCE LISTED IN SCHEDULES II, III AND IV TO ANY PERSON,
4 EXCEPT TO ONE AUTHORIZED BY LAW TO SELL, DISPENSE, PRESCRIBE OR
5 POSSESS SUCH SUBSTANCES, UNLESS UPON THE WRITTEN OR ORAL
6 PRESCRIPTION OF A PERSON LICENSED BY LAW TO PRESCRIBE SUCH DRUG
7 AND UNLESS COMPOUNDED OR DISPENSED BY A REGISTERED PHARMACIST OR
8 PHARMACY INTERN UNDER THE IMMEDIATE PERSONAL SUPERVISION OF A
9 REGISTERED PHARMACIST, OR THE REFILLING OF A WRITTEN OR ORAL
10 PRESCRIPTION ORDER FOR A DRUG, UNLESS SUCH REFILLING IS
11 AUTHORIZED BY THE PRESCRIBER EITHER IN THE ORIGINAL WRITTEN
12 PRESCRIPTION ORDER OR BY WRITTEN CONFIRMATION OF THE ORIGINAL
13 ORAL PRESCRIPTION ORDER. THE PROVISIONS OF THIS SUBSECTION SHALL
14 NOT APPLY TO A PRACTITIONER LICENSED TO PRESCRIBE OR DISPENSE
15 SUCH DRUGS, WHO KEEPS A RECORD OF THE AMOUNT OF SUCH DRUGS
16 PURCHASED AND A DISPENSING RECORD SHOWING THE DATE, NAME, AND
17 QUANTITY OF THE DRUG DISPENSED AND THE NAME AND ADDRESS OF THE
18 PATIENT, AS REQUIRED BY THIS ACT.
19 (16) KNOWINGLY OR INTENTIONALLY POSSESSING A CONTROLLED
20 SUBSTANCE BY A PERSON NOT REGISTERED UNDER THIS ACT, OR A <--
21 PRACTITIONER NOT REGISTERED OR LICENSED BY THE APPROPRIATE STATE
22 BOARD, UNLESS THE SUBSTANCE WAS OBTAINED DIRECTLY FROM, OR
23 PURSUANT TO, A VALID PRESCRIPTION ORDER OR ORDER OF A
24 PRACTITIONER, OR EXCEPT AS OTHERWISE AUTHORIZED BY THIS ACT.
25 (17) THE WILFUL DISPENSING OF A CONTROLLED SUBSTANCE BY A
26 PRACTITIONER OTHERWISE AUTHORIZED BY LAW SO TO DO WITHOUT
27 AFFIXING TO THE CONTAINER IN WHICH THE DRUG IS SOLD OR DISPENSED
28 A LABEL BEARING THE NAME AND ADDRESS OF THE PRACTITIONER, THE
29 DATE DISPENSED, THE NAME OF THE PATIENT AND THE DIRECTIONS FOR
30 THE USE OF THE DRUG BY THE PATIENT.
19710H0851B2553 - 70 -
1 (18) THE SELLING BY A PHARMACY OR DISTRIBUTOR OF ANY
2 CONTROLLED SUBSTANCE OR OTHER DRUG UNLESS THE CONTAINER BEARS A
3 LABEL, SECURELY ATTACHED THERETO, STATING THE SPECIFIC NAME OF
4 THE DRUG AND THE PROPORTION OR AMOUNT THEREOF.
5 (19) THE INTENTIONAL PURCHASE OR KNOWING RECEIPT IN COMMERCE
6 BY ANY PERSON OF ANY CONTROLLED SUBSTANCE, OTHER DRUG OR DEVICE
7 FROM ANY PERSON NOT AUTHORIZED BY LAW TO SELL, DISTRIBUTE,
8 DISPENSE OR OTHERWISE DEAL IN SUCH CONTROLLED SUBSTANCE, OTHER
9 DRUG OR DEVICE.
10 (20) THE USING BY ANY PERSON TO HIS OWN ADVANTAGE OR
11 REVEALING OTHER THAN TO THE SECRETARY OR OFFICERS OR EMPLOYES OF
12 THE DEPARTMENT OR TO THE COUNCIL OR TO THE BOARD OR TO COURTS OR
13 A HEARING EXAMINER WHEN RELEVANT TO PROCEEDINGS UNDER THIS ACT
14 ANY INFORMATION ACQUIRED UNDER AUTHORITY OF THIS ACT CONCERNING
15 ANY METHOD OR PROCESS WHICH AS A TRADE SECRET IS ENTITLED TO
16 PROTECTION. SUCH INFORMATION OBTAINED UNDER THE AUTHORITY OF
17 THIS ACT SHALL NOT BE ADMITTED IN EVIDENCE IN ANY PROCEEDING
18 BEFORE ANY COURT OF THE COMMONWEALTH EXCEPT IN PROCEEDINGS UNDER
19 THIS ACT.
20 (21) THE REFUSAL OR FAILURE TO MAKE, KEEP OR FURNISH ANY
21 RECORD, NOTIFICATION, ORDER FORM, STATEMENT, INVOICE OR
22 INFORMATION REQUIRED UNDER THIS ACT.
23 (22) THE REFUSAL OF ENTRY INTO ANY PREMISES FOR ANY
24 INSPECTION AUTHORIZED BY THIS ACT.
25 (23) THE UNAUTHORIZED REMOVING, BREAKING, INJURING, OR
26 DEFACING A SEAL PLACED UPON EMBARGOED SUBSTANCES OR THE REMOVAL
27 OR DISPOSAL OF SUBSTANCES SO PLACED UNDER SEAL.
28 (24) THE FAILURE BY A MANUFACTURER OR DISTRIBUTOR TO
29 REGISTER OR OBTAIN A LICENSE AS REQUIRED BY THIS ACT.
30 (25) THE MANUFACTURE OF A CONTROLLED SUBSTANCE BY A
19710H0851B2553 - 71 -
1 REGISTRANT WHO KNOWS OR WHO HAS REASON TO KNOW, THE
2 MANUFACTURING IS NOT AUTHORIZED BY HIS REGISTRATION, OR WHO
3 KNOWINGLY DISTRIBUTES A CONTROLLED SUBSTANCE NOT AUTHORIZED BY
4 HIS REGISTRATION TO ANOTHER REGISTRANT OR OTHER AUTHORIZED
5 PERSON.
6 (26) THE KNOWING DISTRIBUTION BY A REGISTRANT OF A
7 CONTROLLED SUBSTANCE CLASSIFIED IN SCHEDULES I OR II, EXCEPT
8 PURSUANT TO AN ORDER FORM AS REQUIRED BY THIS ACT.
9 (27) THE USE IN THE COURSE OF THE MANUFACTURE OR
10 DISTRIBUTION OF A CONTROLLED SUBSTANCE OF A REGISTRATION NUMBER
11 WHICH IS FICTITIOUS, REVOKED, SUSPENDED, OR ISSUED TO ANOTHER
12 PERSON.
13 (28) THE FURNISHING OF FALSE OR FRAUDULENT MATERIAL
14 INFORMATION IN, OR OMISSION OF ANY MATERIAL INFORMATION FROM ANY
15 APPLICATION, REPORT, OR OTHER DOCUMENT REQUIRED TO BE KEPT OR
16 FILED UNDER THIS ACT, OR ANY RECORD REQUIRED TO BE KEPT BY THIS
17 ACT.
18 (29) THE INTENTIONAL MAKING, DISTRIBUTING, OR POSSESSING OF
19 ANY PUNCH, DIE, PLATE, STONE, OR OTHER THING DESIGNED TO PRINT,
20 IMPRINT, OR REPRODUCE THE TRADEMARK, TRADE NAME, OR OTHER
21 IDENTIFYING MARK, IMPRINT, OR SYMBOL OF ANOTHER OR ANY LIKENESS
22 OF ANY OF THE FOREGOING UPON ANY DRUG OR CONTAINER OR LABELING
23 THEREOF SO AS TO RENDER THE DRUG A COUNTERFEIT SUBSTANCE.
24 (30) EXCEPT AS AUTHORIZED BY THIS ACT, THE MANUFACTURE,
25 DELIVERY, OR POSSESSION WITH INTENT TO MANUFACTURE OR DELIVER, A
26 CONTROLLED SUBSTANCE BY A PERSON NOT REGISTERED UNDER THIS ACT, <--
27 OR A PRACTITIONER NOT REGISTERED OR LICENSED BY THE APPROPRIATE
28 STATE BOARD, OR KNOWINGLY CREATING, DELIVERING OR POSSESSING
29 WITH INTENT TO DELIVER, A COUNTERFEIT CONTROLLED SUBSTANCE.
30 (31) NOTWITHSTANDING OTHER SUBSECTIONS OF THIS SECTION, (I)
19710H0851B2553 - 72 -
1 THE POSSESSION OF A SMALL AMOUNT OF MARIHUANA ONLY FOR PERSONAL
2 USE; (II) THE POSSESSION OF A SMALL AMOUNT OF MARIHUANA WITH THE
3 INTENT TO DISTRIBUTE IT BUT NOT TO SELL IT; OR (III) THE
4 DISTRIBUTION OF A SMALL AMOUNT OF MARIHUANA BUT NOT TO SELL IT. <--
5 FOR SALE.
6 FOR PURPOSES OF THIS SUBSECTION, THIRTY (30) GRAMS OR LESS OF <--
7 MARIHUANA OR EIGHT (8) GRAMS OF HASHISH SHALL BE CONSIDERED A
8 SMALL AMOUNT OF MARIHUANA.
9 (B) ANY PERSON WHO VIOLATES ANY OF THE PROVISIONS OF CLAUSES
10 (1) THROUGH (20) OF SUBSECTION (A) SHALL BE GUILTY OF A
11 MISDEMEANOR, AND EXCEPT FOR CLAUSES (4), (6), (7), (8), (9) AND
12 (19) SHALL, ON CONVICTION THEREOF, BE SENTENCED TO IMPRISONMENT
13 NOT EXCEEDING ONE YEAR OR TO PAY A FINE NOT EXCEEDING FIVE
14 THOUSAND DOLLARS ($5,000), OR BOTH AND FOR CLAUSES (4), (6),
15 (7), (8), (9) AND (19) SHALL, ON CONVICTION THEREOF, BE
16 SENTENCED TO IMPRISONMENT NOT EXCEEDING THREE YEARS OR TO PAY A
17 FINE NOT EXCEEDING FIVE THOUSAND DOLLARS ($5,000), OR BOTH; BUT,
18 IF THE VIOLATION IS COMMITTED AFTER A PRIOR CONVICTION OF SUCH
19 PERSON FOR A VIOLATION OF THIS ACT UNDER THIS SECTION HAS BECOME
20 FINAL, SUCH PERSON SHALL BE SENTENCED TO IMPRISONMENT NOT
21 EXCEEDING THREE YEARS OR TO PAY A FINE NOT EXCEEDING TWENTY-FIVE
22 THOUSAND DOLLARS ($25,000), OR BOTH.
23 (C) ANY PERSON WHO VIOLATES THE PROVISIONS OF CLAUSE CLAUSES <--
24 (21), (22) AND (24) OF SUBSECTION (A) SHALL BE GUILTY OF A
25 MISDEMEANOR, AND SHALL, ON CONVICTION THEREOF, BE PUNISHED ONLY
26 AS FOLLOWS:
27 (1) UPON CONVICTION OF THE FIRST SUCH OFFENSE, HE SHALL BE
28 SENTENCED TO IMPRISONMENT NOT EXCEEDING SIX MONTHS, OR TO PAY A
29 FINE NOT EXCEEDING TEN THOUSAND DOLLARS ($10,000), OR BOTH.
30 (2) UPON CONVICTION OF THE SECOND AND SUBSEQUENT OFFENSE, HE
19710H0851B2553 - 73 -
1 SHALL BE SENTENCED TO IMPRISONMENT NOT EXCEEDING TWO YEARS, OR
2 TO PAY A FINE NOT EXCEEDING TWENTY-FIVE THOUSAND DOLLARS
3 ($25,000), OR BOTH.
4 (D) ANY PERSON WHO KNOWINGLY OR INTENTIONALLY VIOLATES ANY <--
5 OF CLAUSES (21) THROUGH CLAUSE (23) OF SUBSECTION (A) IS GUILTY
6 OF A MISDEMEANOR AND UPON CONVICTION THEREOF SHALL BE SENTENCED
7 TO IMPRISONMENT NOT EXCEEDING ONE YEAR THREE YEARS, OR TO PAY A <--
8 FINE NOT EXCEEDING FIFTEEN THOUSAND DOLLARS ($15,000), OR BOTH.
9 (E) ANY PERSON WHO VIOLATES CLAUSES (25) THROUGH (29) OF
10 SUBSECTION (A) IS GUILTY OF A MISDEMEANOR AND UPON CONVICTION
11 SHALL BE SENTENCED TO IMPRISONMENT NOT EXCEEDING THREE YEARS, OR
12 TO PAY A FINE NOT EXCEEDING TWENTY-FIVE THOUSAND DOLLARS
13 ($25,000), OR BOTH.
14 (F) ANY PERSON WHO VIOLATES CLAUSE (30) OF SUBSECTION (A)
15 WITH RESPECT TO:
16 (1) A CONTROLLED SUBSTANCE OR COUNTERFEIT SUBSTANCE
17 CLASSIFIED IN SCHEDULE I OR II WHICH IS A NARCOTIC DRUG, IS
18 GUILTY OF A FELONY AND UPON CONVICTION THEREOF SHALL BE
19 SENTENCED TO IMPRISONMENT NOT EXCEEDING FIFTEEN YEARS, OR TO PAY
20 A FINE NOT EXCEEDING TWO HUNDRED FIFTY THOUSAND DOLLARS
21 ($250,000), OR BOTH.
22 (2) ANY OTHER CONTROLLED SUBSTANCE OR COUNTERFEIT SUBSTANCE
23 CLASSIFIED IN SCHEDULE I, II, OR III, IS GUILTY OF A FELONY AND
24 UPON CONVICTION THEREOF SHALL BE SENTENCED TO IMPRISONMENT NOT
25 EXCEEDING FIVE YEARS, OR TO PAY A FINE NOT EXCEEDING FIFTEEN
26 THOUSAND DOLLARS ($15,000), OR BOTH.
27 (3) A CONTROLLED SUBSTANCE OR COUNTERFEIT SUBSTANCE
28 CLASSIFIED IN SCHEDULE IV, IS GUILTY OF A FELONY AND UPON
29 CONVICTION THEREOF SHALL BE SENTENCED TO IMPRISONMENT NOT
30 EXCEEDING THREE YEARS, OR TO PAY A FINE NOT EXCEEDING TEN
19710H0851B2553 - 74 -
1 THOUSAND DOLLARS ($10,000), OR BOTH.
2 (4) A CONTROLLED SUBSTANCE OR COUNTERFEIT SUBSTANCE
3 CLASSIFIED IN SCHEDULE V, IS GUILTY OF A MISDEMEANOR AND UPON
4 CONVICTION THEREOF SHALL BE SENTENCED TO IMPRISONMENT NOT
5 EXCEEDING ONE YEAR, OR TO PAY A FINE NOT EXCEEDING FIVE THOUSAND
6 DOLLARS ($5,000), OR BOTH.
7 (G) ANY PERSON WHO VIOLATES CLAUSE (31) OF SUBSECTION (A) IS
8 GUILTY OF A MISDEMEANOR AND UPON CONVICTION THEREOF SHALL BE
9 SENTENCED TO IMPRISONMENT NOT EXCEEDING THIRTY DAYS, OR TO PAY A
10 FINE NOT EXCEEDING FIVE HUNDRED DOLLARS ($500), OR BOTH.
11 Section 15. Additional Penalties.--Any (H) ANY penalty <--
12 imposed for violation of this act shall be in addition to, and
13 not in lieu of, any civil or administrative penalty or sanction
14 authorized by law.
15 Section 16. 14. Distribution to Persons Under Age <--
16 Eighteen.--Any person who is at least eighteen TWENTY-ONE years <--
17 of age who violates this act by distributing a controlled
18 dangerous substance listed in Schedules I or II which is a <--
19 narcotic drug THROUGH V to a person under eighteen years of age <--
20 who is at least three FIVE years his junior is punishable by a <--
21 term of imprisonment up to twice that otherwise authorized by
22 subsection (f) (B) (F) of section 14 13 of this act, in addition <--
23 to any fine authorized by this act. Any person who is at least <--
24 eighteen years of age who violates this act by distributing any
25 other controlled drug or controlled dangerous substance listed
26 in Schedules I, II, III, IV and V to a person under eighteen
27 years of age who is at least three years his junior is
28 punishable by a term of imprisonment up to twice that authorized
29 by subsection (f) of section 14 of this act, in addition to any
30 fine authorized by this act. Imposition or execution of such
19710H0851B2553 - 75 -
1 sentence shall not be suspended and probation shall not be
2 granted.
3 SECTION 15. SECOND OR SUBSEQUENT OFFENSE.--(A) ANY PERSON <--
4 CONVICTED OF A SECOND OR SUBSEQUENT OFFENSE UNDER CLAUSE (30) OF
5 SUBSECTION (A) OF SECTION 13 OF THIS ACT OR OF A SIMILAR OFFENSE
6 UNDER ANY STATUTE OF THE UNITED STATES OR OF ANY STATE PRIOR TO
7 THE COMMISSION OF THE SECOND OFFENSE MAY BE IMPRISONED FOR A
8 TERM UP TO TWICE THE TERM OTHERWISE AUTHORIZED, FINED AN AMOUNT
9 UP TO TWICE THAT OTHERWISE AUTHORIZED, OR BOTH.
10 (B) FOR PURPOSES OF THIS SECTION, AN OFFENSE IS CONSIDERED A
11 SECOND OR SUBSEQUENT OFFENSE, IF, PRIOR TO THE COMMISSION OF THE
12 SECOND OFFENSE, THE OFFENDER HAS AT ANY TIME BEEN CONVICTED
13 UNDER THIS ACT OR UNDER ANY STATUTE OF THE UNITED STATES OR OF
14 ANY STATE RELATING TO CONTROLLED SUBSTANCES.
15 Section 17. 16. Enforcement Provisions.--The following <--
16 guidelines shall be applicable in the enforcement of any
17 penalties imposed by this act:
18 (1) No publisher, radio broadcast licensee, or agency or
19 medium for the dissemination of an advertisement, except the
20 manufacturer, distributor or seller of the article to which a
21 false advertisement relates, shall be liable under section 14 12 <--
22 of this act by reason of the dissemination by him of such false
23 advertisement unless he has refused on the request of the
24 secretary to furnish the secretary with the name and post office
25 address of the manufacturer, distributor, seller or advertising
26 agency who causes him to disseminate such advertisement or
27 unless he publishes such advertisement knowing or having good
28 cause to know that it is false or otherwise in violation of the
29 law.
30 (2) For purposes of this section, any adjudication of <--
19710H0851B2553 - 76 -
1 violation or conviction under any Federal or State law or of any <--
2 ordinance of any political subdivision relating to any
3 controlled drug or substance SUBSTANCE OR OTHER DRUG, other than <--
4 a juvenile violation, shall constitute a prior offense if it
5 related to the type of conduct against which a subsequent
6 offense is directed.
7 (3) Any penalty relating to license OR REGISTRATION <--
8 suspension or revocation shall be executed by the appropriate
9 licensing OR REGISTRATION agency upon receipt of a court order <--
10 setting forth the penalty.
11 (4) No person shall be convicted of an offense under section <--
12 14 of this act unless he knew with respect to each element of
13 the offense that he was engaged in the act or omission
14 prescribed, but knowledge that the act or omission constituted a
15 civil or criminal offense shall not be required for conviction.
16 (5) Imprisonment may be imposed for failure to pay all or
17 any part of a fine imposed under this section only when the
18 offender does not show that such failure is caused by indigence
19 or a lack of sufficient funds.
20 (6) All fines collected under this section shall be utilized
21 for the treatment and rehabilitation services established by
22 law.
23 (7) (4) The probation or parole or other conditional release <--
24 OR DISCHARGE of any drug abuser or drug dependent person <--
25 convicted of an offense under this act or of any other offense
26 may be conditioned on the person's agreement to periodic urine <--
27 analyses. Neither a URINALYSES OR OTHER REASONABLE MEANS OF <--
28 DETECTION. A relapse into drug abuse one or more times or the
29 failure to conform to a set schedule for rehabilitation, or
30 both, shall be sufficient in themselves to SHALL NOT require <--
19710H0851B2553 - 77 -
1 that his status be revoked or treatment denied.
2 (8) The court without a jury shall hold a full and fair <--
3 hearing for the purpose of setting the amount of any fine
4 pursuant to this section, during which the district attorney and
5 the defendant may introduce evidence. The defendant shall be
6 permitted to cross-examine any adverse witness or rebut any
7 adverse evidence. The amount of any fine set by the court shall
8 be supported by substantial evidence.
9 (9) SECTION 17. PROBATION WITHOUT VERDICT.--A person may be <--
10 entitled to probation without verdict under the following
11 circumstances:
12 (i) (1) A person who has not previously been convicted of an <--
13 offense relating to a controlled drug or controlled dangerous <--
14 substance under any law of this Commonwealth, UNDER THIS ACT OR <--
15 UNDER A SIMILAR ACT OF the United States, or any other state,
16 shall be IS eligible for probation without verdict if he pleads <--
17 nolo contendere or guilty to, or is found guilty of, any
18 NONVIOLENT offense under this act. The court may, without <--
19 entering a judgment, and with the consent of such person, defer
20 further proceedings and place him on probation for a specific
21 time period NOT TO EXCEED THE MAXIMUM FOR THE OFFENSE upon such <--
22 reasonable terms and conditions as it may require. Probation <--
23 without verdict shall not be available to any such person who is
24 charged with a trafficking offense involving distribution of a
25 controlled drug or controlled dangerous substance at wholesale
26 or distribution at retail of any controlled drug or controlled
27 dangerous substance as part of an organized professional system.
28 (ii) (2) Upon violation of a term or condition of probation, <--
29 the court may enter a judgment and proceed as in any criminal
30 case, or may continue the probation without verdict.
19710H0851B2553 - 78 -
1 (iii) (3) Upon fulfillment of the terms and conditions of <--
2 probation, the court shall discharge such person and dismiss the
3 proceedings against him. Discharge and dismissal shall be
4 without adjudication of guilt and shall not constitute a
5 conviction for any purpose whatever, INCLUDING THE PENALTIES <--
6 IMPOSED FOR SECOND OR SUBSEQUENT CONVICTIONS: Provided, That
7 probation without verdict shall be available to any person only
8 once: AND FURTHER PROVIDED, THAT NOTWITHSTANDING ANY OTHER <--
9 PROVISION OF THIS ACT, THE PROSECUTING ATTORNEY OR THE COURT MAY
10 KEEP A LIST OF THOSE PERSONS PLACED ON PROBATION WITHOUT
11 VERDICT, WHICH LIST MAY ONLY BE USED TO DETERMINE THE
12 ELIGIBILITY OF PERSONS FOR PROBATION WITHOUT VERDICT.
13 SECTION 18. DISPOSITION IN LIEU OF TRIAL.--(A) IF A PERSON
14 CHARGED WITH A NONVIOLENT CRIME CLAIMS TO BE DRUG DEPENDENT OR A
15 DRUG ABUSER AND PRIOR TO TRIAL HE REQUESTS APPROPRIATE
16 TREATMENT, INCLUDING BUT NOT LIMITED TO, ADMISSION OR COMMITMENT
17 UNDER THE MENTAL HEALTH AND MENTAL RETARDATION ACT OF 1966 IN
18 LIEU OF CRIMINAL PROSECUTION, A PHYSICIAN EXPERIENCED OR TRAINED
19 IN THE FIELD OF DRUG DEPENDENCY OR DRUG ABUSE SHALL BE APPOINTED
20 BY THE COURT TO EXAMINE, IF NECESSARY, AND TO REVIEW THE
21 ACCUSED'S RECORD AND ADVISE THE GOVERNMENT ATTORNEY, THE ACCUSED
22 AND THE COURT IN WRITING SETTING FORTH THAT FOR THE TREATMENT
23 AND REHABILITATION OF THE ACCUSED IT WOULD BE PREFERABLE FOR THE
24 CRIMINAL CHARGES TO BE HELD IN ABEYANCE OR WITHDRAWN IN ORDER TO
25 INSTITUTE TREATMENT FOR DRUG DEPENDENCE OR FOR THE CRIMINAL
26 CHARGES TO BE PROSECUTED. THE GOVERNMENT ATTORNEY SHALL EXERCISE
27 HIS DISCRETION WHETHER OR NOT TO ACCEPT THE PHYSICIAN'S
28 RECOMMENDATION.
29 (B) IN THE EVENT THAT HE DOES NOT ACCEPT THE PHYSICIAN'S
30 RECOMMENDATION HE SHALL STATE IN WRITING AND FURNISH THE
19710H0851B2553 - 79 -
1 DEFENDANT A COPY OF HIS DECISION AND THE REASONS THEREFOR.
2 (C) IF THE GOVERNMENT ATTORNEY ACCEPTS THE PHYSICIAN'S
3 ADVICE TO HOLD IN ABEYANCE, HE SHALL ARRANGE FOR A HEARING
4 BEFORE THE APPROPRIATE COURT TO HOLD IN ABEYANCE THE CRIMINAL
5 PROSECUTION. THE COURT, UPON ITS APPROVAL, SHALL PROCEED TO MAKE
6 APPROPRIATE ARRANGEMENTS FOR TREATMENT.
7 (D) THE GOVERNMENT ATTORNEY, UPON HIS OWN APPLICATION, MAY
8 INSTITUTE PROCEEDINGS FOR APPROPRIATE TREATMENT, INCLUDING BUT
9 NOT LIMITED TO, COMMITMENT PURSUANT TO THE MENTAL HEALTH AND
10 MENTAL RETARDATION ACT OF 1966.
11 (E) A CRIMINAL CHARGE MAY BE HELD IN ABEYANCE PURSUANT TO
12 THIS SECTION FOR NO LONGER THAN THE LESSER OF EITHER (I) THE
13 APPROPRIATE STATUTE OF LIMITATIONS OR (II) THE MAXIMUM TERM THAT
14 COULD BE IMPOSED FOR THE OFFENSE CHARGED. AT THE EXPIRATION OF
15 SUCH PERIOD, THE CRIMINAL CHARGE SHALL BE AUTOMATICALLY
16 DISMISSED. A CRIMINAL CHARGE MAY NOT BE PROSECUTED EXCEPT BY
17 ORDER OF COURT SO LONG AS THE MEDICAL DIRECTOR OF THE TREATMENT
18 FACILITY CERTIFIES THAT THE ACCUSED IS COOPERATING IN A
19 PRESCRIBED TREATMENT PROGRAM AND IS BENEFITING FROM TREATMENT.
20 (F) IF, AFTER CONVICTION, THE DEFENDANT REQUESTS PROBATION
21 WITH TREATMENT OR CIVIL COMMITMENT FOR TREATMENT IN LIEU OF
22 CRIMINAL PUNISHMENT THE COURT MAY APPOINT A QUALIFIED PHYSICIAN
23 TO ADVISE THE COURT IN WRITING WHETHER IT WOULD BE PREFERABLE
24 FOR THE PURPOSES OF TREATMENT AND REHABILITATION FOR HIM TO
25 RECEIVE A SUSPENDED SENTENCE AND PROBATION ON THE CONDITION THAT
26 HE UNDERGO EDUCATION AND TREATMENT FOR DRUG ABUSE AND DRUG
27 DEPENDENCY, OR TO BE COMMITTED PURSUANT TO THE MENTAL HEALTH AND
28 MENTAL RETARDATION ACT OF 1966 FOR TREATMENT IN LIEU OF CRIMINAL
29 PUNISHMENT, OR TO RECEIVE CRIMINAL INCARCERATION. A COPY OF THE
30 PHYSICIAN'S REPORT SHALL BE FURNISHED THE COURT, THE DEFENDANT
19710H0851B2553 - 80 -
1 AND THE GOVERNMENT ATTORNEY. THE COURT SHALL EXERCISE ITS
2 DISCRETION WHETHER TO ACCEPT THE PHYSICIAN'S ADVICE.
3 (G) DISPOSITION IN LIEU OF TRIAL AS PROVIDED IN THIS SECTION
4 SHALL BE AVAILABLE TO ANY PERSON ONLY ONCE.
5 SECTION 19. EXPUNGING CRIMINAL RECORDS.--(A) ANY RECORDS OF
6 ARREST OR PROSECUTION OR BOTH FOR A CRIMINAL OFFENSE UNDER THIS
7 ACT OR UNDER THE PROVISIONS PREVIOUSLY GOVERNING CONTROLLED
8 SUBSTANCES IN THE COMMONWEALTH OF PENNSYLVANIA OR ANY POLITICAL
9 SUBDIVISION THEREOF SHALL BE PROMPTLY EXPUNGED FROM THE OFFICIAL
10 AND UNOFFICIAL ARREST AND OTHER CRIMINAL RECORDS, FILES AND
11 OTHER DOCUMENTS PERTAINING TO THE PARTICULAR ARREST OR
12 PROSECUTION OR BOTH WHEN THE CHARGES ARE WITHDRAWN OR DISMISSED
13 OR THE PERSON IS ACQUITTED OF THE CHARGES: PROVIDED THAT SUCH
14 EXPUNGMENT SHALL BE AVAILABLE AS A MATTER OF RIGHT TO ANY PERSON
15 ONLY ONCE. WITHIN FIVE DAYS AFTER SUCH WITHDRAWAL, DISMISSAL OR
16 ACQUITTAL THE COURT, IN WRITING, SHALL ORDER THE APPROPRIATE
17 KEEPERS OF CRIMINAL RECORDS (I) TO EXPUNGE AND DESTROY THE
18 OFFICIAL AND UNOFFICIAL ARREST AND OTHER CRIMINAL RECORDS, FILES
19 AND OTHER DOCUMENTS PERTAINING TO THE ARREST OR PROSECUTION OR
20 BOTH, TO REQUEST IN SO FAR AS THEY ARE ABLE THE RETURN OF SUCH
21 RECORDS AS THEY HAVE MADE AVAILABLE TO FEDERAL AND OTHER STATE
22 AGENCIES, AND TO DESTROY SUCH RECORDS ON RECEIPT THEREOF; AND
23 (II) TO FILE WITH THE COURT WITHIN THIRTY DAYS AN AFFIDAVIT THAT
24 SUCH RECORDS HAVE BEEN EXPUNGED AND DESTROYED, TOGETHER WITH THE
25 COURT'S EXPUNCTION ORDER AND TO RETAIN NO COPIES THEREOF. UPON
26 RECEIPT OF SUCH AFFIDAVIT, THE COURT SHALL SEAL THE SAME
27 TOGETHER WITH THE ORIGINAL AND ALL COPIES OF ITS EXPUNCTION
28 ORDER AND SHALL NOT PERMIT ANY PERSON OR AGENCY TO EXAMINE SUCH
29 SEALED DOCUMENTS.
30 (B) ANY EXPUNGED RECORD OF ARREST OR PROSECUTION SHALL NOT
19710H0851B2553 - 81 -
1 HEREAFTER BE REGARDED AS AN ARREST OR PROSECUTION FOR THE
2 PURPOSE OF ANY STATUTE OR REGULATION OR LICENSE OR QUESTIONNAIRE
3 OR ANY CIVIL OR CRIMINAL PROCEEDING OR ANY OTHER PUBLIC OR
4 PRIVATE PURPOSE. NO PERSON SHALL BE PERMITTED TO LEARN OF AN
5 EXPUNGED ARREST OR PROSECUTION, OR OF THE EXPUNCTION, EITHER
6 DIRECTLY OR INDIRECTLY. ANY PERSON, EXCEPT THE INDIVIDUAL
7 ARRESTED OR PROSECUTED, WHO DIVULGES SUCH INFORMATION IN
8 VIOLATION OF THIS SUBSECTION SHALL BE GUILTY OF A MISDEMEANOR
9 AND SHALL, UPON CONVICTION THEREOF, BE PUNISHED BY IMPRISONMENT
10 NOT EXCEEDING NINETY (90) DAYS OR A FINE NOT EXCEEDING ONE
11 THOUSAND DOLLARS ($1,000), OR BOTH.
12 (C) NOTHING CONTAINED IN THIS SECTION SHALL PROHIBIT A
13 PERSON ACTING PURSUANT TO PRIOR PRACTICE FROM PETITIONING AN
14 APPROPRIATE COURT FOR AN EXPUNCTION ORDER.
15 Section 18. 20. Offenses by a Corporation, Copartnership or <--
16 Association.--If any violation of the provisions of this act is
17 by a corporation, copartnership or association, the officers and
18 directors of such corporation or the members of such
19 copartnership or association, the agents and employes with prior
20 guilty knowledge of the fact, shall be deemed guilty of a
21 violation of the provisions of this act to the same extent as
22 though said violation were committed by them personally.
23 Section 19. Expunging Criminal Records.--(a) Any arrest for <--
24 a criminal offense under this act or under the provisions
25 previously governing narcotics and dangerous drugs or substances <--
26 in the Commonwealth of Pennsylvania, or any political
27 subdivision thereof, shall promptly be expunged from the
28 person's public arrest and other public criminal records when
29 the charges are withdrawn or dismissed or the person is
30 acquitted of the charges.
19710H0851B2553 - 82 -
1 (b) Any conviction of a criminal offense under this act or
2 under the provisions previously governing narcotics and
3 dangerous drugs or substances in the Commonwealth of
4 Pennsylvania or any political subdivision thereof may be
5 expunged from all public criminal records by a court upon the
6 filing of a petition supported by substantial evidence of good
7 conduct since the petitioner's conviction. Copies of the
8 petition shall be served on the Attorney General and the
9 district attorney, who shall be responsible for consulting other
10 appropriate public agencies and departments. If a district
11 attorney files a motion to dismiss the petition within sixty
12 days, the court, without a jury, shall hold a full and fair
13 hearing before ruling on the issue. The petitioner shall have
14 the right to cross-examine any adverse witness or rebut any
15 adverse evidence. The proceeding shall be private. The petition
16 shall be granted if supported by substantial evidence of good
17 conduct since the petitioner's conviction unless the court
18 finds, on the basis of evidence of record, good cause not to
19 accept the petitioner's allegations of good conduct. The
20 petition may be filed and heard only after the following time
21 lapses:
22 (1) For a conviction for trafficking in the third degree or
23 possession in the second degree, or any offense under prior law
24 that would not come within any of these provisions, after two
25 years from the date or release from a penal institution or from
26 the date of conviction if not sent to a penal institution.
27 (2) For a conviction for possession in the first degree, or
28 any offense under prior law that would not come within any of
29 these provisions, after three years from the date of release
30 from a penal institution or from the date of conviction if not
19710H0851B2553 - 83 -
1 sent to a penal institution.
2 (3) For a conviction for any other offense under this act,
3 or any offense under prior law that would now come within any of
4 these provisions, or any offense under prior law governing
5 narcotics and controlled drugs or controlled dangerous
6 substances that would not now come within any of these
7 provisions, after three years from the date of release from a
8 penal institution or from the date of conviction if not sent to
9 a penal institution.
10 (c) Any expunged arrest or conviction shall not thereafter
11 be regarded as an arrest or conviction for the purpose of any
12 statute or regulation or license or questionnaire or any other
13 public or private purpose: Provided, That it shall continue to
14 constitute an offense for purposes of any criminal statute under
15 which the existence of a prior conviction is relevant to the
16 penalty to be imposed. No person shall be permitted to learn of
17 an expunged arrest or conviction, or of the expungement, by any
18 means whatever: Provided, That the judiciary, court personnel,
19 and district attorneys may learn of an expunged arrest or
20 conviction, and of the expungement, where it becomes relevant to
21 a penalty to be imposed in a subsequent case. Any person who
22 seeks or divulges such information in violation of this
23 subsection shall be guilty of a misdemeanor, and shall, upon
24 conviction thereof be punished by imprisonment not exceeding
25 ninety days, or a fine not exceeding one thousand dollars
26 ($1,000), or both.
27 Section 20. 21. Burden of Proving Exemptions.--In any <--
28 prosecution under this act, it shall not be necessary to negate
29 any of the exemptions OR EXCEPTIONS of this act in any <--
30 complaint, information or indictment TRIAL. The burden of <--
19710H0851B2553 - 84 -
1 proving any exemption under this act shall be upon the <--
2 defendant. PROOF OF SUCH EXEMPTION OR EXCEPTION SHALL BE UPON <--
3 THE PERSON CLAIMING IT.
4 SECTION 22. JUDICIAL REVIEW.--ANY PERSON AGGRIEVED BY A
5 FINAL ADMINISTRATIVE DECISION MAY OBTAIN REVIEW OF THE DECISION
6 PURSUANT TO THE PROVISIONS OF THE ADMINISTRATIVE AGENCY LAW.
7 Section 21. 23. Revocation of Licenses of Practitioners.-- <--
8 (a) Any license OR REGISTRATION heretofore issued to any <--
9 physician, dentist, veterinarian, pharmacist or nurse may be <--
10 either PRACTITIONER MAY EITHER BE revoked or suspended by the <--
11 proper officers or boards having power to issue licenses OR <--
12 REGISTRATION to any of the foregoing, upon proof that the
13 licensee OR REGISTRANT is addicted to A DRUG DEPENDENT PERSON ON <--
14 the use of any narcotic drugs CONTROLLED SUBSTANCE after giving <--
15 such licensee OR REGISTRANT reasonable notice and opportunity to <--
16 be heard.
17 (b) The appropriate licensing boards in the Department of
18 State are hereby authorized to revoke or suspend the
19 registration or license of any physician, surgeon, dentist, <--
20 veterinarian, pharmacist or nurse, PRACTITIONER when such person <--
21 has pleaded guilty or nolo contendere or has been found guilty <--
22 by a judge or jury of violating CONVICTED OF A FELONY UNDER THIS <--
23 ACT OR any SIMILAR State or Federal law. pertaining to the sale, <--
24 use or distribution of narcotics. Before any such revocation or
25 suspension, the licensee or registrant shall be given a hearing
26 before the appropriate board. At such hearing the accused may be
27 represented by counsel and shall be entitled to compulsory
28 attendance of witnesses.
29 Section 22. 24. Administrative Inspections and Warrants.-- <--
30 (a) As used in this section, the term "controlled premises"
19710H0851B2553 - 85 -
1 means:
2 (1) Places where original or other records or documents
3 required under this act are kept or required to be kept; and
4 (2) Places, including factories, warehouses, or other
5 establishments, and conveyances, where persons registered under
6 section 6 (or exempted from registration under section 6) may
7 lawfully hold, manufacture, or distribute, dispense, administer
8 or otherwise dispose of controlled dangerous substances. <--
9 (b) (1) For the purpose of inspecting, copying, and
10 verifying the correctness of records, reports, or other
11 documents required to be kept or made under this act and
12 otherwise facilitating the carrying out of his functions under
13 this act, the Secretary of Health SECRETARY is authorized, in <--
14 accordance with this section, to enter controlled premises and
15 to conduct administrative inspections thereof, and of the things
16 specified in this section, relevant to those functions.
17 (2) Such entries and inspections shall be carried out
18 through officers or employes (hereinafter referred to as
19 "agents" "OFFICERS") designated by the secretary. Any such agent <--
20 OFFICER upon stating his purpose and presenting to the owner, <--
21 operator, or agent OFFICER in charge of such premises (i) <--
22 appropriate credentials and (ii) a written notice of his
23 inspection authority (which notice in the case of an inspection
24 requiring, or in fact supported by, an administrative inspection
25 warrant shall consist of such warrant), shall have the right to
26 enter such premises and conduct such inspection at reasonable
27 times.
28 (3) Except as may otherwise be indicated in an applicable
29 inspection warrant, the agent OFFICER shall have the right: (i) <--
30 to inspect and copy records, reports, and other documents
19710H0851B2553 - 86 -
1 required to be kept or made under this act; (ii) to inspect,
2 within reasonable limits and in a reasonable manner, controlled
3 premises and all pertinent equipment, finished and unfinished
4 drugs and other substances or materials, containers, and
5 labeling found therein, and, except as provided in clause (5) of <--
6 this subsection, all other things therein (including records,
7 files, papers, processes, controls, and facilities) appropriate
8 for verification of the records, reports, and documents referred
9 to in subclause (i) or otherwise bearing on the provisions of
10 this act; and (iii) to inventory any stock of any controlled
11 substance, OTHER DRUG, DEVICE AND COSMETIC therein and obtain <--
12 samples of any such substance OR ARTICLE. <--
13 (4) Except when the owner, operator, or agent OFFICER in <--
14 charge of the controlled premises so consents in writing, no
15 inspection authorized by this section shall extend to: (i)
16 financial data; (ii) sales data other than shipment data; or <--
17 (iii) pricing data; OR (IV) RESEARCH DATA. <--
18 (c) A warrant under this section shall not be required for
19 the inspection of books and records pursuant to an
20 administrative subpoena issued in accordance with any provisions
21 of any Act of Assembly nor for entries and administrative
22 inspections (including seizures of property):
23 (1) With the consent of the owner, operator, or agent <--
24 OFFICER in charge of the controlled premises; <--
25 (2) In situations presenting imminent danger to health or
26 safety;
27 (3) In situations involving inspection of conveyances where
28 there is reasonable cause to believe that the mobility of the
29 conveyance makes it impracticable to obtain a warrant;
30 (4) In any other exceptional or emergency circumstance where
19710H0851B2553 - 87 -
1 time or opportunity to apply for a warrant is lacking; or
2 (5) In any other situations where a warrant is not
3 constitutionally required.
4 (d) Issuance and execution of administrative inspection
5 warrants shall be as follows:
6 (1) Any judge of a Commonwealth court of record COURT, may, <--
7 within his territorial jurisdiction, and upon proper oath or
8 affirmation showing probable cause, issue warrants for the
9 purpose of conducting administrative inspections authorized by
10 this act or regulations thereunder, and seizures of property
11 appropriate to such inspections. For the purposes of this
12 section, the term "probable cause" means EXISTS UPON SHOWING a <--
13 valid public interest in the effective enforcement of this act
14 or regulations thereunder sufficient to justify administrative
15 inspections of the area, premises, building, or conveyance, or
16 contents thereof, in the circumstances specified in the
17 application for the warrant.
18 (2) A warrant shall issue only upon an affidavit of an A <--
19 DESIGNATED officer or employe having knowledge of the facts
20 alleged, sworn to before the judge and establishing the grounds
21 for issuing the warrant. If the judge is satisfied that grounds
22 for the application exist or that there is probable cause to
23 believe they exist, he shall issue a warrant identifying the
24 area, premises, building, or conveyance to be inspected, the
25 purpose of such inspection, and, where appropriate, the type of
26 property to be inspected, if any. The warrant shall identify the
27 items or types of property to be seized, if any. The warrant
28 shall be directed to a person authorized under subsection (b)
29 (2) to execute it. The warrant shall state the grounds for its
30 issuance and the name of the person or persons whose affidavit
19710H0851B2553 - 88 -
1 has been taken in support thereof. It shall command the person
2 to whom it is directed to inspect the area, premises, building,
3 or conveyance identified for the purpose specified, and, where
4 appropriate, shall direct the seizure of the property specified.
5 The warrant shall direct that it be served during normal
6 business hours. It shall designate the judge to whom it shall be
7 returned.
8 (3) A warrant issued pursuant to this section must be
9 executed and returned within ten days of its date unless, upon a
10 showing by the Secretary of Health SECRETARY of a need therefor, <--
11 the judge allows additional time in the warrant. If property is
12 seized pursuant to a warrant, the person executing the warrant
13 shall give to the person from whom or from whose premises the
14 property was taken a copy of the warrant and a receipt for the
15 property taken or shall leave the copy and receipt at the place
16 from which the property was taken. The return of the warrant
17 shall be made promptly and shall be accompanied by a written
18 inventory of any property taken. The inventory shall be made in
19 the presence of the person executing the warrant and of the
20 person from whose possession or premises the property was taken,
21 if they are present, or in the presence of at least one credible
22 person other than the person making such inventory, and shall be
23 verified by the person executing the warrant. The judge upon <--
24 request, shall deliver a A copy of the inventory SHALL BE <--
25 DELIVERED to the person from whom or from whose premises the
26 property was taken and to the applicant for the warrant.
27 (4) The judge who has issued a warrant under this section
28 shall attach to the warrant a copy of the return and all papers
29 RETURNABLE filed in connection therewith and shall file them <--
30 with the clerk of the court for the judicial district in which
19710H0851B2553 - 89 -
1 the inspection was made.
2 Section 23. 25. Injunctive Relief.--In addition to the <--
3 remedies provided herein, the secretary is hereby authorized to
4 apply to the court of common pleas in the county in which such
5 violation occurs or to the Commonwealth Court for, and such
6 court shall have jurisdiction to grant, a temporary or permanent
7 injunction restraining any person from continued violation of
8 any provision of this act irrespective of the existence of an
9 adequate remedy at law.
10 Section 24. 26. Cooperation With Other Authorities.--The <--
11 agencies charged with the enforcement of this act shall actively
12 cooperate and coordinate with the agencies charged with the
13 enforcement of all Federal and State laws relating to the
14 regulation of the distribution of controlled drugs or dangerous <--
15 substances, OTHER DRUGS, DEVICES OR COSMETICS. <--
16 Section 25. 27. Embargo and Seizure.--(a) Whenever a duly <--
17 authorized agent OFFICER of the secretary finds or has probable <--
18 cause to believe that any CONTROLLED SUBSTANCE, OTHER drug, <--
19 device or cosmetic is adulterated or misbranded or contraband,
20 the same shall be deemed subject to embargo and he shall affix
21 to such SUBSTANCE OR article or articles a tag or other <--
22 appropriate marking, approved by the secretary, giving notice
23 that such SUBSTANCE OR article is or is suspected of being <--
24 adulterated, misbranded or contraband and warning all persons
25 not to remove or dispose of such SUBSTANCE OR article or <--
26 articles until permission so to do has been granted by such
27 agent OFFICER, or until it shall have determined by proper <--
28 authority that such SUBSTANCE OR article or articles are IS not <--
29 adulterated, misbranded or contraband. At the time such notice
30 is offered, the agent OFFICER shall provide the person in charge <--
19710H0851B2553 - 90 -
1 of such articles SUBSTANCE OR ARTICLE, if any, or the owner, if <--
2 he is known, a statement in writing, setting forth both the
3 basis for the embargo and supporting facts.
4 (b) When an article or articles A SUBSTANCE OR ARTICLE is <--
5 detained or embargoed under subsection (a), the secretary shall
6 serve within three days from the date of such embargo a citation
7 upon the claimant thereof or owner, if he is known, setting
8 forth both the basis for the embargo and supporting facts and
9 fixing a date for a hearing not later than ten days from the
10 date of service of said citation at which a hearing examiner,
11 appointed under the authority of section 27 30, will receive <--
12 evidence pertaining to the alleged offense. Unless postponed by
13 mutual consent, failure to serve a citation or commence hearings
14 within the time herein specified shall operate to void such
15 embargo.
16 (c) If, after hearing, the examiner is satisfied from the
17 evidence presented that a detained or embargoed SUBSTANCE OR <--
18 article is adulterated, misbranded or contraband, he shall,
19 within five days of the conclusion of the hearing, order such
20 SUBSTANCE OR article or articles destroyed at the expense of the <--
21 claimant thereof under supervision of an agent of the secretary:
22 Provided, That when the embargo is based on an adulteration or
23 misbranding which can be corrected by proper labeling or
24 processing of the SUBSTANCE OR article, the examiner, after <--
25 entry of the order and after such costs, fees and expenses have
26 been paid and a good and sufficient bond conditioned that such
27 SUBSTANCE OR article shall be so labeled or processed has been <--
28 executed, may by order direct that such SUBSTANCE OR article be <--
29 released to the claimant thereof for such labeling or processing
30 under the supervision of an agent OFFICER of the secretary. The <--
19710H0851B2553 - 91 -
1 expense of such supervision, if any, shall be paid by the
2 claimant. Such SUBSTANCE OR article shall be released to the <--
3 claimant of the article when the article WHEN IT is no longer in <--
4 violation of this act and the expenses of such supervision have
5 been paid.
6 (d) If no claimant shall appear to defend such proceedings,
7 the hearing examiner may order the embargoed SUBSTANCES OR <--
8 articles destroyed or distributed to a nonprofit institution.
9 Section 26. 28. Forfeiture.--(a) The following shall be <--
10 subject to forfeiture to the Commonwealth and no property right
11 shall exist in them:
12 (1) All controlled paraphernalia SUBSTANCES OR OTHER DRUGS <--
13 which have been manufactured, distributed, dispensed, or
14 acquired in violation of this act.
15 (2) All raw materials, products, and equipment of any kind
16 which are used, or intended for use in manufacturing,
17 compounding, processing, delivering, importing, or exporting any
18 controlled dangerous substance OR OTHER DRUG in violation of <--
19 this act.
20 (3) All property which is used, or intended for use, as a
21 container for property described in clause (1) or (2) of this
22 subsection.
23 (4) All conveyances, including aircraft, vehicles, or
24 vessels, which are used or are intended for use, to transport,
25 or in any manner to facilitate the transportation, sale,
26 receipt, possession, or concealment of property described in
27 clause (1) or (2) except that:
28 (i) no conveyance used by any person as a common carrier in
29 the transaction of business as a common carrier shall be
30 forfeited under the provisions of this section unless it shall
19710H0851B2553 - 92 -
1 appear that the owner or other person in charge of such
2 conveyance was a consenting party or privy to a violation of
3 this title; and <--
4 (ii) no conveyance shall be forfeited under the provisions
5 of this section by reason of any act or omission established by
6 the owner thereof to have been committed or omitted without his
7 knowledge or consent; AND <--
8 (iii) No perfected BONA FIDE security interest retained or <--
9 acquired under the Uniform Commercial Code by any merchant
10 dealing in new or used aircraft, vehicles or vessels, or
11 retained or acquired by any licensed or regulated finance
12 company, bank, lending institution, or by any other business
13 regularly engaged in the financing of, or lending on the
14 security of, such aircraft, vehicles or vessels, shall be
15 subject to forfeiture or impairment. under the provisions of <--
16 this subheading.
17 (5) All books, records, and research, including formulas,
18 microfilm, tapes and data which are used, or intended for use,
19 in violation of this act.
20 (b) Property subject to forfeiture under this act may be
21 seized by the law enforcement authority upon process issued by
22 any court of common pleas having jurisdiction over the property.
23 Seizure without process may be made if:
24 (1) The seizure is incident to an arrest or a search under a
25 search warrant or inspection under an administrative inspection
26 warrant;
27 (2) The property subject to seizure has been the subject of
28 a prior judgment in favor of the Commonwealth in a criminal
29 injunction or forfeiture proceeding under this act;
30 (3) There is probable cause to believe that the property is
19710H0851B2553 - 93 -
1 directly or indirectly dangerous to health or safety; or <--
2 (4) There is probable cause to believe that the property has
3 been used or is intended to be used in violation of this act.
4 (c) In the event seizure without process occurs, as provided
5 herein, proceedings for the issuance thereof shall be instituted
6 promptly. FORTHWITH. <--
7 (d) Property taken or detained under this section shall not
8 be subject to replevin, but is deemed to be in the custody of
9 the law enforcement authority subject only to the orders and
10 decrees of the court of common pleas having jurisdiction over
11 the forfeiture proceedings AND OF THE SECRETARY. When property <--
12 is seized under this act, the law enforcement authority may: <--
13 SHALL: <--
14 (1) Place the property under seal; AND EITHER <--
15 (2) Remove the property to a place designated by it; or
16 (3) Require that the proper administrative authority <--
17 DEPARTMENT take custody of the property and remove it to an <--
18 appropriate location for disposition in accordance with law.
19 (e) Whenever property is forfeited under this act, the law <--
20 enforcement authority may: PROPERTY SHALL BE TRANSFERRED TO THE <--
21 CUSTODY OF THE DEPARTMENT AND THE SECRETARY MAY:
22 (1) Retain the property for official use;
23 (2) Sell any forfeited property which is not required to be
24 destroyed by law and which is not harmful to the public, but the
25 proceeds from any such sale shall be used to pay all proper
26 expenses of the proceedings for forfeiture and sale including
27 expenses of seizure, maintenance of custody, advertising and
28 court costs. <--
29 (3) Require that the appropriate administrative agency take <--
30 custody of the property and remove it for disposition in
19710H0851B2553 - 94 -
1 accordance with law; or
2 (4) Forward it to the council, or its successor agency, for
3 disposition.
4 (f) Procedure with respect to seized property subject to
5 liens and rights of lienholders:
6 (1) Notification of owner of confiscated vehicle, vessel or
7 aircraft. The person or governmental agency that
8 SECTION 29. PROCEDURE WITH RESPECT TO SEIZED PROPERTY <--
9 SUBJECT TO LIENS AND RIGHTS OF LIENHOLDERS.--(A) THE PERSON WHO
10 seized said property shall notify the registered owner and
11 lienholder, where possible, and shall publish notice in a
12 newspaper of general circulation in the county or the city,
13 where seized, of any vehicle, vessel or aircraft confiscated
14 under this subheading, informing interested persons of the <--
15 seizure and right to file a claim protesting the confiscation of
16 said vehicle, vessel or aircraft.
17 (2) Claim for return of confiscated property. (B) Any lawful <--
18 lienholder, or other person showing a legal right, title or
19 interest in a vehicle, vessel or aircraft, confiscated pursuant
20 to this subtitle may, within thirty days of publication of
21 notice file a claim protesting such seizure with the court or
22 with the person or governmental agency having jurisdiction <--
23 thereof. When such a claim is filed, the court of common pleas
24 of the county wherein the property was confiscated, shall
25 proceed in rem to hear and determine the question of forfeiture.
26 (3) Rights of lienholders. (C) If the court determines any <--
27 property is subject to forfeiture it shall also determine
28 whether any lawful lienholder who has filed a timely claim and
29 protest had knowledge of such intended unlawful use. If the
30 court shall find such knowledge then the lienholder's right,
19710H0851B2553 - 95 -
1 title and interest to the property shall likewise be deemed
2 forfeited. If the court does not find such knowledge and the
3 property is otherwise subject to forfeiture, it shall be
4 forfeited and the person or agency having custody of such <--
5 property shall either pay the outstanding indebtedness secured
6 by such lawful lien and keep the property or deliver the
7 property to the said lienholder.
8 Section 27. 30. Hearing Examiners.--(a) The secretary shall <--
9 appoint, with the approval of the Governor, such hearing
10 examiners as shall be necessary to conduct hearings as provided
11 in section 25 27. <--
12 (b) Hearing examiners appointed under this act shall have
13 the power to issue subpoenas requiring the attendance and
14 testimony of, or the production of, pertinent books and papers
15 by persons whom they believe to have information relevant to any
16 matter pending before him. Such examiner shall also have the
17 power to administer oaths.
18 (c) Any person who refuses to obey a subpoena issued
19 hereunder or to be sworn or affirmed or to testify, or who is
20 guilty of any contempt after summons to appear, may be punished
21 as for contempt of court. For this purpose, an application may
22 be made by the examiner to the court of common pleas within the
23 territorial jurisdiction of which the offense was committed for
24 which purpose such court is hereby given jurisdiction.
25 (d) In any action or proceeding before him, the hearing
26 examiner may assess all costs incurred in connection with the
27 prosecution of such proceeding, including investigative and
28 laboratory costs incurred by the Commonwealth, against
29 respondent in such proceeding; such costs to be in addition to
30 any other penalty imposed and to be retained by the Department
19710H0851B2553 - 96 -
1 of Health and applied to cost to the department administering
2 this act.
3 (e) Hearings shall be conducted under the provisions of the
4 Administrative Agency Law, as amended, and subject to such other
5 rules and regulations not inconsistent therewith as the
6 secretary may provide and any person aggrieved by any action of
7 the hearing examiner may appeal in accordance with the
8 provisions of the Administrative Agency Law, as amended.
9 Section 28. 31. Board Creation.--(a) There is hereby created <--
10 within the Department of Health a departmental administrative
11 board to be known as the "Pennsylvania Drug, Device and Cosmetic
12 Board."
13 (b) The board shall consist of the Secretary of Health, his
14 successors in office, and ten additional members whom the
15 Governor shall appoint, by and with the advice and consent of
16 two-thirds of all the members of the Senate. Of the members: one
17 shall be a physician, one a dentist, one a veterinarian, one a
18 psychologist OR PSYCHIATRIST and one a pharmacist, each of whom <--
19 shall be duly licensed in their respective professions by the
20 Commonwealth; one shall be a biochemist and one shall be a
21 pharmacologist, each of whom shall have earned an advanced
22 degree in that field from an institution of higher learning and
23 shall have been engaged as such for three years in this State;
24 one shall be a manufacturer registered to manufacture drugs or
25 an employe thereof; and the two remaining persons shall be
26 members of the general public not engaged in any of the
27 aforementioned professional fields, who shall be citizens of <--
28 this State. BUT ONE OF WHOM SHALL BE WELL INFORMED ON THE <--
29 PROBLEMS CAUSED BY THE ABUSE AND MISUSE OF DRUGS OR OTHER
30 CHEMICALS. Two members initially shall serve for terms of one,
19710H0851B2553 - 97 -
1 two, three and four years, respectively, the particular term of
2 each to be designated by the Governor at the time of
3 appointment. Any additional member, the appointment of whom is
4 authorized by amending act, shall serve for a term of four
5 years. The terms of all their successors shall be four years
6 each, except that any person appointed to fill a vacancy shall
7 serve only for the unexpired term. Every member's term shall
8 extend until his successor is appointed and qualified. Any
9 appointed member of the board shall be eligible for
10 reappointment. Each member of the board shall receive
11 compensation at a rate of thirty dollars ($30) FIFTY DOLLARS <--
12 ($50) per diem in addition to expenses incurred when actually
13 engaged in official meetings or otherwise in the performance of
14 their official duties as directed by the chairman.
15 (c) The Secretary of Health, or his designate, shall serve
16 as chairman of the board. A majority of the members shall
17 constitute a quorum for the purpose of organizing the board,
18 conducting its business, and exercising all of its powers. A
19 vote of the majority of the members present shall be sufficient
20 for all actions of the board unless the bylaws require a greater
21 number.
22 (d) The board shall have the power to prescribe, amend and
23 repeal bylaws, rules and regulations governing the manner in
24 which the business of the body is conducted and the manner in
25 which the powers granted to it are exercised. The board may
26 delegate supervision of the administration of board activities
27 to an administrative secretary and such other employes as the
28 Secretary of Health shall appoint.
29 (e) The board shall have the power to do all things
30 necessary or convenient to carry out the powers granted to it by
19710H0851B2553 - 98 -
1 this act.
2 (f) The board may, for the authentication of its records,
3 process and proceedings, adopt, keep and use a common seal of
4 which seal judicial notice shall be taken in all courts of this
5 Commonwealth and any process, writ, notice or other document,
6 which the board may be authorized by law to issue, shall be
7 deemed sufficient if signed by the chairman or secretary of the
8 board and authenticated by such seal. All acts, proceedings,
9 orders, papers, findings, minutes and records of the board, and
10 all reports and documents filed with the board, may be proved in
11 any court of this Commonwealth by a copy thereof certified to by
12 the chairman or secretary of the board with the seal of the
13 board attached.
14 (g) In order to enable the board to carry out the provisions
15 of this act, including its power to advise the secretary on
16 various matters, it shall have the power to issue subpoenas,
17 requiring the attendance and testimony of, or the production of,
18 pertinent books and papers by persons whom the board believes to
19 have information, books or papers of importance to it in
20 carrying out the purposes and intent of this act. Each member of
21 the board and such officers, employes or others employed in the
22 work of the board designated by the chairman of the board also
23 shall have the power to administer oaths and affirmations, to
24 question witnesses thereunder, and to examine such books and
25 papers. The board may issue commissions, letters rogatory, or
26 other appropriate processes outside the Commonwealth.
27 (h) Any person who refuses to obey a subpoena issued
28 hereunder, or to be sworn or affirmed, or to testify, or who is
29 guilty of any contempt after summons to appear, may be punished
30 as for contempt of court. For this purpose an application may be
19710H0851B2553 - 99 -
1 made by the board to the court of common pleas within the
2 territorial jurisdiction of which the offense was committed, for
3 which purpose, such court is hereby given jurisdiction.
4 Section 29. 32. Persons Authorized to Prescribe Drugs to <--
5 Remain as Heretofore.--No provision of this act or any rule or
6 regulation promulgated pursuant to this act shall authorize or
7 be construed as authorizing any person to prescribe drugs who is
8 not specifically so authorized under existing law.
9 Section 30. 33. Conformity With Federal Law.--No CONTROLLED <--
10 SUBSTANCE, OTHER drug, device or cosmetic shall be deemed to be
11 adulterated or misbranded under this act if such drug, device or <--
12 cosmetic IT complies with the applicable Federal act and/or <--
13 regulations and interpretations issued pursuant thereto, unless
14 the secretary, after consultation with and upon the
15 recommendation of the board, shall have previously promulgated a
16 regulation stating that the applicable provision of the Federal
17 act and/or regulations and interpretations thereof would not be
18 followed.
19 Section 31. 34. Administration of Act.--(a) Except as may be <--
20 otherwise provided by law, the provisions of this act shall be
21 administered by the Department of Health of the Commonwealth of <--
22 Pennsylvania. DEPARTMENT. The Secretary of Health SECRETARY is <--
23 authorized to employ such consultants, assistants, <--
24 stenographers, clerks and other employes as, in his opinion, may
25 be necessary PERSONNEL and to fix their compensation subject to <--
26 THE ACT OF APRIL 9, 1929 (P.L.177), KNOWN AS "The Administrative <--
27 Code of 1929," 1929." as amended, act of April 9, 1929 <--
28 (P.L.177).
29 (b) The secretary is authorized and directed to establish a
30 Bureau of Narcotics Control within the department and to employ
19710H0851B2553 - 100 -
1 therein sufficient law enforcement personnel to act as agents
2 for the purpose of performing the inspection, training,
3 prevention and enforcement duties imposed upon the department by
4 this act.
5 (c) Any officer or employe of the Bureau of Narcotics of the
6 department may:
7 (B) THE SECRETARY IS AUTHORIZED AND DIRECTED TO ESTABLISH A <--
8 BUREAU OF DRUG CONTROL WITHIN THE DEPARTMENT AND TO EMPLOY
9 THEREIN SUFFICIENT PERSONNEL TO PERFORM THE DUTIES IMPOSED UPON
10 THE DEPARTMENT BY THIS ACT.
11 (C) THE SECRETARY MAY DESIGNATE SPECIFIC OFFICERS AND
12 EMPLOYES OF THE BUREAU OF DRUG CONTROL AS LAW ENFORCEMENT
13 PERSONNEL AND AUTHORIZE SUCH PERSONNEL TO:
14 (1) Carry firearms in the performance of his official
15 duties;
16 (2) Execute and serve search warrants, arrest warrants,
17 administrative inspection warrants, subpoenas, and summonses
18 issued under the authority of the Commonwealth;
19 (3) Make arrests without warrant for any offense under this
20 act committed in his presence, or if he has probable cause to
21 believe that the person to be arrested has committed or is
22 committing a violation of this act which may constitute a
23 felony;
24 (4) Make seizures of property pursuant to this act; or
25 (5) Perform other law enforcement duties as the secretary
26 designates.
27 (d) Nothing contained herein shall be deemed to limit the
28 authority of the Bureau of Narcotics Control or DRUG CONTROL, <--
29 THE PENNSYLVANIA STATE POLICE, the Department of Justice or any
30 other law enforcement agency in dealing with law enforcement
19710H0851B2553 - 101 -
1 matters with respect to professional criminals PERSONS engaged <--
2 in the unlawful importation, manufacture, DISTRIBUTION, sale and <--
3 production of drugs and controlled dangerous substances, OTHER <--
4 DRUGS OR DEVICES OR COSMETICS nor the authority of the council
5 in performing any duties imposed upon it by the "Pennsylvania
6 Drug Narcotic and Alcohol Abuse Act of 1971." ACT." <--
7 Section 32. 35. Promulgation of Regulations.--(a) The <--
8 secretary shall have the authority to promulgate in accordance
9 with the provisions of this section and of the act of July 31,
10 1968 (Act No. 240), known as the "Commonwealth Documents Law"
11 any regulations hereinbefore referred to in this act and such
12 other regulations upon the advice WITH THE CONSENT of the board <--
13 regarding the possession, DISTRIBUTION, sale, purchase or <--
14 manufacture of CONTROLLED SUBSTANCES, OTHER drugs OR devices or <--
15 cosmetics as may be necessary to aid in the enforcement of this
16 act.
17 (b) (i) Prior to the promulgation, amendment or repeal of <--
18 any regulation under this act the secretary shall give at least
19 thirty days public notice of his proposed action, and shall
20 afford all interested persons an opportunity to present their
21 views thereon either orally or in writing. As soon as
22 practicable thereafter, the secretary shall either withdraw such
23 proposal or shall promulgate the proposed regulation.
24 (ii) Any person aggrieved by the promulgation, amendment or
25 repeal of a regulation, or by the refusal to promulgate, amend
26 or repeal a regulation, may file objections with the secretary
27 specifying, with particularity, the reason why such action is
28 deemed objectionable and the grounds for such objection. As soon
29 as possible after the filing of objections, the secretary shall
30 hold a public hearing for the purpose of receiving evidence
19710H0851B2553 - 102 -
1 relevant to such objections. As soon as practicable after
2 completion of hearings, the secretary shall issue an appropriate
3 order either confirming, modifying or withdrawing the regulation
4 in question.
5 (iii) Any party to proceedings, conducted pursuant to
6 paragraph (ii) hereof, aggrieved by the order of the secretary,
7 shall have a right of appeal in accordance with the provisions
8 of the Administrative Agency Law, as amended, and such order
9 shall be deemed an "adjudication" as that term is defined and
10 used in the Administrative Agency Law, as amended.
11 Section 33. 36. Administrative Procedure.--The <--
12 Administrative Agency Law, as amended, shall be applicable in
13 its entirety to the Department of Health in the administration
14 of this act.
15 SECTION 37. COOPERATIVE AGREEMENTS AND CONFIDENTIALITY.--(A) <--
16 THE SECRETARY SHALL COOPERATE WITH FEDERAL AND OTHER STATE
17 AGENCIES IN DISCHARGING HIS RESPONSIBILITIES CONCERNING TRAFFIC
18 IN CONTROLLED SUBSTANCES, OTHER DRUGS, DEVICES AND COSMETICS AND
19 IN SUPPRESSING THE ABUSE OF SUCH SUBSTANCES AND ARTICLES. TO
20 THIS END, HE MAY:
21 (1) ARRANGE FOR THE EXCHANGE OF INFORMATION AMONG
22 GOVERNMENTAL OFFICIALS CONCERNING THE USE AND ABUSE OF SUCH
23 SUBSTANCES AND ARTICLES;
24 (2) COORDINATE AND COOPERATE IN TRAINING PROGRAMS CONCERNING
25 LAW ENFORCEMENT AT LOCAL AND STATE LEVELS;
26 (3) REQUEST THE FEDERAL BUREAU OF NARCOTICS AND DANGEROUS
27 DRUGS TO ESTABLISH A CENTRALIZED UNIT TO COLLECT, ACCEPT,
28 CATALOGUE AND FILE NONCONFIDENTIAL STATISTICS AND MAKE THE
29 INFORMATION AVAILABLE FOR FEDERAL, STATE AND LOCAL LAW
30 ENFORCEMENT PURPOSES; AND
19710H0851B2553 - 103 -
1 (4) CONDUCT PROGRAMS OF ERADICATION AIMED AT DESTROYING WILD
2 OR ILLICIT GROWTH OF PLANT SPECIES FROM WHICH DRUGS MAY BE
3 EXTRACTED.
4 (B) RESULTS, INFORMATION, AND EVIDENCE RECEIVED FROM THE
5 BUREAU RELATING TO THE REGULATORY FUNCTIONS OF THIS ACT,
6 INCLUDING RESULTS OF INSPECTIONS CONDUCTED BY IT MAY BE RELIED
7 AND ACTED UPON BY THE SECRETARY IN THE EXERCISE OF HIS
8 REGULATORY FUNCTIONS UNDER THIS ACT.
9 (C) A PRACTITIONER ENGAGED IN MEDICAL PRACTICE OR CLINICAL
10 RESEARCH IS NOT REQUIRED NOR MAY HE BE COMPELLED TO FURNISH THE
11 NAME OR IDENTITY OF A PATIENT OR RESEARCH SUBJECT TO THE
12 SECRETARY, NOR MAY HE BE COMPELLED IN ANY STATE OR LOCAL CIVIL,
13 CRIMINAL, ADMINISTRATIVE, LEGISLATIVE OR OTHER PROCEEDINGS TO
14 FURNISH THE NAME OR IDENTITY OF SUCH AN INDIVIDUAL.
15 (D) THIS SECTION SHALL NOT EXEMPT THE PRACTITIONER FROM
16 REGULATIONS OF THE SECRETARY PERTAINING TO THE PRESCRIPTION OF
17 CONTROLLED SUBSTANCES TO A PATIENT OVER AN EXTENDED PERIOD OR IN
18 AN INCREASINGLY LARGE DOSAGE.
19 Section 34. 38. Savings Provision.--The provisions of this <--
20 act shall not affect any act done, liability incurred, or right
21 accrued or vested, or affect any suit or prosecution pending to
22 enforce any right or penalty or punish any offense under the
23 authority of any Act of Assembly, or part thereof, repealed by
24 this act.
25 Section 35. Severability.--The provisions of this act are <--
26 severable and, if any provision or part hereof shall be held
27 invalid or unconstitutional or inapplicable to any person or
28 circumstances, such invalidity, unconstitutionality or
29 inapplicability shall not affect or impair the remaining
30 provisions of the act. It is hereby declared to be the
19710H0851B2553 - 104 -
1 legislative intent that this act would have been adopted if such
2 invalid, unconstitutional or inapplicable provision had not been
3 included therein.
4 SECTION 39. PENDING PROCEEDINGS.--(A) PROSECUTION FOR ANY <--
5 VIOLATION OF LAW OCCURRING PRIOR TO THE EFFECTIVE DATE OF THIS
6 ACT IS NOT AFFECTED OR ABATED BY THIS ACT. IN ANY CASE NOT YET
7 FINAL IF THE OFFENSE IS SIMILAR TO ONE SET OUT IN THIS ACT, THE
8 PENALTIES UNDER THIS ACT APPLY IF THEY ARE LESS THAN THOSE UNDER
9 PRIOR LAW.
10 (B) CIVIL SEIZURES OR FORFEITURES AND INJUNCTIVE PROCEEDINGS
11 COMMENCED PRIOR TO THE EFFECTIVE DATE OF THIS ACT ARE NOT
12 AFFECTED BY THIS ACT.
13 (C) ALL ADMINISTRATIVE PROCEEDINGS PENDING UNDER PRIOR LAWS
14 WHICH ARE SUPERSEDED BY THIS ACT SHALL BE CONTINUED AND BROUGHT
15 TO A FINAL DETERMINATION IN ACCORD WITH THE LAWS AND RULES IN
16 EFFECT PRIOR TO THE EFFECTIVE DATE OF THE ACT. ANY SUBSTANCE
17 CONTROLLED UNDER PRIOR LAW WHICH IS NOT LISTED WITHIN SCHEDULES
18 I THROUGH V, IS AUTOMATICALLY CONTROLLED WITHOUT FURTHER
19 PROCEEDINGS AND SHALL BE LISTED IN THE APPROPRIATE SCHEDULE.
20 (D) THE SECRETARY SHALL INITIALLY PERMIT PERSONS TO REGISTER
21 WHO OWN OR OPERATE ANY ESTABLISHMENT ENGAGED IN THE MANUFACTURE
22 OR DISTRIBUTION OF ANY CONTROLLED SUBSTANCE PRIOR TO THE
23 EFFECTIVE DATE OF THIS ACT AND WHO ARE REGISTERED OR LICENSED BY
24 THIS COMMONWEALTH.
25 (E) THIS ACT APPLIES TO VIOLATIONS OF LAW, SEIZURES AND
26 FORFEITURES, INJUNCTIVE PROCEEDINGS, ADMINISTRATIVE PROCEEDINGS
27 AND INVESTIGATIONS WHICH OCCUR FOLLOWING ITS EFFECTIVE DATE.
28 SECTION 40. CONTINUATION OF REGULATIONS.--ANY ORDERS AND
29 REGULATIONS PROMULGATED UNDER ANY LAW AFFECTED BY THIS ACT AND
30 IN EFFECT ON THE EFFECTIVE DATE OF THIS ACT AND NOT IN CONFLICT
19710H0851B2553 - 105 -
1 WITH IT CONTINUE IN EFFECT UNTIL MODIFIED, SUPERSEDED OR
2 REPEALED.
3 SECTION 41. UNIFORMITY OF INTERPRETATION.--THIS ACT SHALL BE
4 SO APPLIED AND CONSTRUED AS TO EFFECTUATE ITS GENERAL PURPOSE TO
5 MAKE UNIFORM THE LAW WITH RESPECT TO THE SUBJECT OF THIS ACT
6 AMONG THOSE STATES WHICH ENACT SIMILAR LEGISLATION.
7 SECTION 42. BAR TO PROSECUTION.--IF A VIOLATION OF THIS ACT
8 IS A VIOLATION OF A FEDERAL LAW OR THE LAW OF ANOTHER STATE, A
9 CONVICTION OR ACQUITTAL UNDER FEDERAL LAW OR THE LAW OF ANOTHER
10 STATE FOR THE SAME ACT IS A BAR TO PROSECUTION IN THIS
11 COMMONWEALTH.
12 Section 36. 43. Repeals.--(a) The act of September 26, 1961 <--
13 (P.L.1664), known as "The Drug, Device and Cosmetic Act," is
14 hereby repealed.
15 (b) All other acts, or parts of acts, inconsistent with this
16 act are hereby repealed.
17 Section 37. Effective Date.--This act shall take effect <--
18 sixty days after the enactment thereof.
D22L32JH/19710H0851B2553 - 106 -